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The problem addressed by this dissertation is the separation of 
optical isomers in commercial as well as biological samples. The 
chromatographic separation of enantiomers is an important and rapidly 
developing field of study. 
Chiral separations of pharmaceutical compounds and 
important organic intermediates in high performance liquid 
chromatography (HPLC) and thin layer chromatography (TLC) were 
achieved. Two methods were employed for the direct liquid 
chromatographic resolution of chiral analytes: chiral stationary phases 
(CSPs) and chiral mobile phase additives (CMAs). Native and derivatized 
J3-cyclodextrins (J3-CD) were used as chiral stationary phases in reverse 
phase and normal phase HPLC, respectively. This study marked the first 
use of derivatized J3-CDs for chiral separations in normal phase media. N-
carbobenzoxy-glycyl-L-proline and (lR)-(-)-ammonium-10-
camphorsulfonate were utilized as CMAs in normal phase TLC for the 
resolution of several aromatic amino alcohols. Maltosyl-J3-CD and 
hydroxypropyl-J3-CD were employed as CMAs in reverse phase TLC. A 
study was conducted with hydroxypropyl-(3-CD to determine how the 
degree of substitution of a derivatized CD could effect development time, 
the viscosity of the solution and the enantioselectivity. 
In addition, studies were initiated to determine the presence of 
trace levels of D-amino acids in: amniotic fluid, blood serum and urine. 
The blood and urine of healthy young adults were analyzed and found to 
contain trace to percent levels of D-amino acids. The human amniotic fluid 
samples did not have detectable levels of D-amino acids. 
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I. INTRODUCTION 
A substantial amount of research has been conducted in the area of 
chiral separations due to the demand for efficient, precise and dependable 
methods for the determination of optical purity and/or preparative scale 
separation of optical isomers (enantiomers). One reason for this effort is 
the fact that two enantiomeric forms of a molecule can have different 
effects in biological systems ( 1 ), and as the need for information on the 
often widely variant activities of enantiomers of pharmacologically 
important compounds increases, the demand for chiral separation methods 
will continue. Differences in biological activity of drugs, agrochemicals, 
etc., may originate due to dissimilarities in: protein binding and transport, 
mechanism of action, metabolism rates, changes in activity due to 
metabolism, clearance rates, and persistence in the environment. Another 
important use for enantioselective separations is to check reaction progress 
and purity (% composition of each enantiomer, quality control, etc.) 
during asymmetric syntheses. 
The chromatographic separation of enantiomers is an important and 
rapidly developing field of study. There has been a dramatic increase in 
the number and nature of racemic separations obtained by chromatographic 
methods. The development of fast and productive chiral separation 
methods continues to escalate. These separation methods involve the use of 
chiral counter ions/chiral mobile phase additives (CMA) in thin layer 
chromatography (TLC) and high performance liquid chromatography 
(HPLC), and of chiral stationary phases (CSP) in TLC, HPLC and gas 
chromatography (GC). 
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Consequently, manufacturers in pharmaceutical, pesticide, and food 
and beverage industries now have the means to tailor the preparation of 
products which contain optically active compounds. It has been reported 
that approximately 57% of the active pharmaceutical compounds 
prescribed in the United States contain at least one stereogenic center (2, 
3). The biological activity of two enantiomeric forms of an active drug 
can be significantly different. For example, it was found that the L-form 
of thalidomide is a powerful teratogen and the D-form is a sedative and 
soporific drug ( 4, 5). The administration of the racemate D, L-
thalidomide to pregnant women during the 1960's was associated with a 
large number of newborn abnormalities. This drug was withdrawn from 
the market a few years later. Another example of a drug which exhibits 
enantioselective biological activity is propranolol. Propranolol is a (3-
adrenergic blocker. The (S) enantiomer of propranolol is about 100 times 
as potent as the (R) isomer (2, 6). Such differences in pharmacological 
activity between enantiomers is often the rule rather than the exception. 
However, in the period 1983-1985, 88% of the new chiral drugs 
introduced were marketed as racemates (3). Many individuals believe that 
racemic pharmaceuticals will soon be considered as drugs with 50% 
impurity (2, 3, 5). 
Regulatory authorities have begun requesting data on stereochemistry 
as knowledge of the biological importance of chirality increases. The 
awareness that the efficacy and toxicology of enantiomers may differ from 
each other and from the racemic mixture continues to grow. Studies 
indicate that metabolism can produce chiral metabolites from non-chiral 
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Figure 1. Examples of reactions which could ·produce chiral metabolites 
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Recently, the Food and Drug Administration (FDA) has issued 
guidelines on the submission of New Drug Applications (NDAs) which 
addresses the question of stereochemistry in the manufacturing of drug 
substances (8). The Food, Drug and Cosmetic (FD & C) Act requires a 
complete description of the "methods used in the manufacture of the drug" 
which includes testing to demonstrate its identity, strength, quality and 
purity. Consequently, the decision of whether to market the racemate in 
preference to a pure enantiomer must now be justified by the submission of 
relevant information. 
The significance of stereoisomerism in relation to biological activity 
has been recognized since Pasteur reported the first separation of 
enantiomers. The question to be answered was 'Why are living systems 
chirally discriminating?'. The answer was that living systems are 
composed of chiral molecules. Therefore the human body is a highly 
stereospecific environment and in nature, biological asymmetry at the 
molecular level is the norm, not the exception. 
All naturally occurring amino acids are L-amina acids and most 
natural sugars are D-sugars. There are twenty primary protein 
constituents which consist of 19 L-a-amino acids and one cyclic L-a-imino 
acid, proline (9). Phospholipids, steroids, nucleotides, nucleosides, and bile 
salts are other examples of chiral molecules of biological necessity. 
Over 50 years ago Kogl and Erxleben (10) reported the presence of 
D-amino acids in the hydrosylates of tumor proteins. Although most other 
investigators believed that the D-amino acids were produced via 
racemization during the acid hydrolysis step, the controversy went on for 
over a decade (11, 12). Currently, there is not a lot of conclusive evidence 
for the occurrence of D-amino acids in the proteins of man. However, 
there is undisputed evidence for the occurrence of both free and bound D-
amino acids in a variety of micro-organisms (13). Given the central 
importance of amino acids in all living systems and their use in the 
diagnosis of certain disorders or diseases in man, it seems logical to 
investigate all possible aspects of these compounds 
5 
Amino acid analysis has been used in biochemistry for the 
determination of free amino acids and to study proteins, i.e.,- purity, 
quantitation, composition, sequencing, etc. The separation of amino acids 
on cation exchange resins has been the preferred technique for their 
quantitation in both hydrosylates and physiological fluids since the classic 
studies of Moore and Stein (14, 15). The ease of quantitation was greatly 
enhanced by the development of the automatic analyzer (16). Although 
ion-exchange chron1atography has been the main method for amino acid 
analysis, recently the technology associated with HPLC has been applied 
with increasing success. The comprehensive studies on the 
chromatography of amino acids performed by Hamilton (17 :-19) in the late 
1950s was echoed in HPLC literature. Modem HPLC equipment has 
recently achieved the level of sophistication which was standard in amino 
acid analyzers a decade ago. It should be emphasized that ion exchange 
chromatography of amino acids depicts one specific application of the 
general analytical procedure of liquid column chromatography and that 
high performance (or high pressure) liquid chromatography is the 
terminology applied to the technique as currently optimized. 
The interest in HPLC lies in the speed, economy, and ease of this 
technique in comparison to that of conventional ion-exchange methodology. 
The development of HPLC technology for amino acid analysis is lacking 
for underivatized samples but it is possible to attain fast sensitive 
separations for many amino acid derivatives (20, 21 ). There have been a 
few reports in the literature concerning the analysis of free amino acids 
using reversed-phase HPLC (22). Nonpolar stationary phases have been 
successful in attaining separations of underivatized amino acids but the 
resolution is not comparable to that obtained in conventional ion-exchange 
chromatography. 
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Resolved samples of chiral amino acids are now required for the 
majority of amino acid analyses. Chiral amino acids can be obtained from 
the following: (a) natural source, (b) asymmetric synthesis, or (c) 
resolution of a D, L amino acid obtained through synthesis. 
There are two methods for the direct liquid chromatographic analysis 
of chiral compounds: chiral stationary phases and chiral mobile phase 
additives. The formation of reversible diastereomeric complexes with the 
CMA or the CSP is the basis for the chromatographic resolution of optical 
isomers. Enantiomers have identical chemical and physical properties in an 
isotropic environment but diastereomers may display dissimilar properties 
in isotropic environments; this difference makes it possible to separate 
diastereomers. Differences in the distribution properties of the 
diastereomeric complex may be due to differences in the binding strength 
to the adsorbent and/or to dissimilarities in the complex solvation or 
solubility in the mobile phase. 
There have been several reports on using CMAs in chromatographic 
analysis. Numerous racemic mixtures can be resolved on conventional 
achiral LC columns by utilizing the proper chiral additive in the mobile 
phase. The first to report this beneficial innovation were Gil-Av and co-
workers (23) and Karger and associates (24) utilizing ligand exchange 
chromatography (LEC). In LEC, a transition metal ion such as Cu(II) or 
7 
Zn(II) must be added to the mobile phase. The CMA consisted of a chiral 
bidentate ligand with a hydrophobic moiety. The ligand strongly associates 
with the reverse-phase media due to its hydrophobic segment. Suitable 
racemic analytes, particularly amino acids, form ternary complexes which 
are retained by the stationary phase. 
Chiral separations have also been obtained using suitable CMAs with 
achiral stationary phases in reversed-phase (25) and normal-phase (26) 
modes. The selectivities of these CMAs sometimes differ from those of 
available CSPs. Most of the recent work done in normal phase HPLC 
involved the use of chiral counter ions. Pettersson and Schill reported the 
separation of enantiomers by "ion-pair" chromatography using quinine, 
camphorsulfonic acid, albumin, and n-dibutyl tartrate as chiral counter ions 
(27). Pettersson and Josefsson reported the separation of racemic 
aromatic amino alcohols in ion interaction chromatographic systems using 
N-carbobenzoxy-glycyl-L-proline (ZGP) (28). Knox and Jurad reported 
the separation of optical isomers by zwitterion-pair chromatography; the 
chiral agent in this case was L-leucyl-L-leucyl-L-leucine (29). 
Research involving the use of CMAs in HPLC has revealed several 
important parameters: the nature of the solid phase, the concentration and 
nature of the CMA and the amount of polar modifier in the mobile phase 
(27). Consequently, the use of CMAs is a viable but relatively unexplored 
approach to chiral separations. 
Cyclodextrins (CD) have proven useful as chiral stationary phases 
(CSPs) and as chiral mobile phase additives (CMAs) but their low solubility 
in hydro-organic solvents has limited their applicability as CMA in the 
reversed-phase (RP) mode. The solubility of B-CD in pure water is 1.67 x 
1 Q-2 M at 250 C. Chiral resolution was attained only when the 
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concentration of ~-CD was increased to levels surpassing its solubility in 
neat water. Two approaches have been used to overcome the solubility 
problem. One approach takes advantage of the fact that it is possible to 
increase the solubility of the native CD by the addition of urea or sodium 
hydroxide to the mobile phase (30). Aqueous solutions saturated with urea 
were more effective in attaining chiral separations than aqueous solutions 
containing sodium hydroxide. The proposed separation mechanism for the 
native COs in the reversed-phase mode involved the formation of an 
inclusion complex, driven by hydrophobic interactions, in which each 
enantiomer is complexed somewhat differently in the CD cavity. Disparate 
retention times are noted for the optical isomers. The relative size and 
geometry of the guest molecule in relation to the dimensions of the host CD 
cavity are important parameters in determining if an inclusion complex can 
be formed (31 ). Other parameters include: the concentration of the CMA, 
the concentration and the type of organic modifier in the mobile phase, and 
the retention behavior of enantiomers. 
Another approach benefits from the enhanced solubility of derivatized 
cyclodextrins in hydro-organic solvents relative to that of the native CD. 
The derivatization process involves the formation of ethers due to the 
addition of propylene oxide to the hydroxy groups on the mouth and base 
of the CD cavity. Armstrong, Faulkner, and Han separated a variety of 
racemic compounds using hydroxypropyl- and hydroxyethyl- derivatized 
~-CD as CMAs (32). 
The majority of reports of CD as a CMA are for TLC whereas most 
applications of CD-CSPs are for work in HPLC or GC. Although many 
compounds separate well with both methods, it is interesting to note that 
sometimes there is a poor correlation between the enantiomeric separations 
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obtained with CD-CMA versus CD-CSP. Reasons for this discrepancy may 
be: (1) ~-CD is linked to the silica gel via an 6-10 atom spacer and these 
spacer arms may provide additional interaction sites for the complexed 
analyte and/or these arms may restrict motion of the CD; (2) if the CD is 
in the mobile phase, it is available for multiple complexation. The most 
notable difference that has been observed between the use of CD as CMA 
and CSP in reversed-phase media is the reversal of elution order of 
enantiomers. For example, with DL amino acid derivatives, the D 
enantiomer elutes ahead of the L enantiomer when the chiral agent is in the 
mobile phase but a reversal of the retention behavior is noted if the chiral 
selector is bonded to the stationary phase, exclusively (30). 
Cyclodextrin bonded phases have been used for the reversed phase 
separation of a variety of enantiomers (33), diastereoisomers (34 ), 
structural isomers (34 ), enzymes (35), and routine compounds (36). Of 
these, the enantiomeric separations probably have received the greatest 
attention. In order to evaluate the mechanism of enantioselective 
chromatography, a number of empirical and theoretical studies have been 
done (37 -41 ). In specific cases involving cyclodextrins, the formation of 
an inclusion complex seems to be a fundamental part of the chiral 
recognition and separation process (33, 34, 36, 41). As yet, there have 
been no reports of normal phase, enantiomeric separations on native 
cyclodextrin bonded phase columns. Indeed, the fact that facile 
enantiomeric resolution obtained in the reversed phase-mode could not be 
duplicated in the normal phase-mode has been used as indirect evidence to 
support the premise that inclusion complexation is necessary for 
enantioselectivity ( 41 ). However, native cyclodextrin bonded phases have 
been used successfully in nonnal phase LC for a number of achiral 
separations ( 42-44 ). The retention behavior was somewhat like that of a 
diol column. It is believed that the nonpolar portion of the mobile phase 
(e.g., hexane, heptane, etc.) occupies the cavity of cyclodextrin and that 
solute retention was due mainly to interaction with the external hydroxyl 
groups that line the top and bottom of the cyclodextrin torus ( 42-45). 
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Among the available CSPs for LC are the polymeric chiral phases 
(46), the crown ether phases (47), the protein CSPs (48, 49), the 1t-
complex, hydrogen bond CSPs (Pirkle-type) (50), and the cyclodextrin 
(CD) bonded CSPs (33). The number of commercially available HPLC-
CSP has risen to over fifty and has continued to grow annually (51). There 
have been several reviews of HPLC-CSPs which were designed to help 
determine which CSP to use for a particular problem (52-56). It should be 
noted that research has concentrated on HPLC while the progress in TLC 
has advanced much more slowly. 
There have been relatively few reports of CSP for TLC and only for a 
limited number of compounds. Yuasa announced the partial separation of 
D, L-tryptophan on a crystalline cellulose-coated plate (57). Wainer, eta/. 
published the separation of racemic 2, 2, 2-trifluoro-1-(9-anthryl)ethanol 
on a chiral dinitrobenzoylphenylglycine bonded phase (58). Brunner, eta/. 
reported the use of a naphthylethylurea TLC-CSP for the separation of 
enantiomeric amides (59). Alak and Armstrong published the separation of 
several racemic amino acids and ferrocene derivatives on a ~-cyclodextrin 
bonded phase (60). While ~-CD was used successively as a bonded TLC 
phase, attempts to coat a TLC plate with ~-CD were unsuccessful (61). 
The problem with coating the plates was due to the low solubility of ~-CD 
in organic solvents. Weinstein (62), Grinberg and Weinstein (63), and 
Gunther, et al. (64) reported the separation of several racemic dansyl 
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amino acids on reversed-phase (RP) plates impregnated with copper (II) 
complexes of chiral alkyl a-amino acid derivatives. Results obtained with 
TLC-CSPs are comparable to those obtained using analogous HPLC-CSPs. 
At this time, the only CSPs which are commercially available for TLC are 
the ternary complex-ligand exchange plates. Some of the problems in 
developing chiral TLC plates were discussed by Wilson (61). 
Several important differences exist between HPLC and TLC. The 
major advantage that HPLC has over TLC is better reproducibility, greater 
sensitivity and more theoretical plates. The fact that the HPLC column is 
equilibrated with the mobile phase before use whereas the TLC stationary 
phase is initially dry has resulted in several important differences. The 
quantity of mobile phase in the bed varies according to location on the TLC 
plate, such that the phase ratio varies during development. Second, heat is 
given off when a solvent wets a dry bed and this results in a small 
temperature differential between the solvent front and the rest of the bed. 
Third, in TLC, the mobile phase may change composition during 
development of a binary or more complex solvent due to differential 
adsorption on the stationary phase. In addition, the velocity of the solvent 
front is inversely proportional to the distance that the solvent front has 
traveled, so the flow rate is not constant with time or distance. Also, the 
amount of chiral agent in the mobile phase may change with TLC due to 
preferential adsorption of the chiral selector as the solvent front migrates 
along the chromatographic bed. In contrast, the concentration of the CMA 
remains constant during high performance liquid chromatographic analysis 
due to pre-equilibration of the LC column. 
An advantage of HPLC is that the analyst can choose between gradient 
or isocratic elution. It is also possible to change the flow rate in HPLC to 
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optimize separations. Precise control of pH and ionic strength during the 
separation process and ease of temperature control are additional 
advantages offered by high performance LC. Despite these differences, it 
is sometimes possible to attain similar results with both chromatographic 
methods. 
TLC has achieved popularity due to its simplicity, low cost and wide 
versatility and applicability. In his review, Stahl stated that TLC was the 
easiest and most economical chromatographic technique for fast separation 
and visual evaluation (65). The main advantage of TLC over HPLC has 
been the ability to screen a large number of compounds concurrently 
thereby saving time and operating expenses. One problem that has been 
noted is t!·;c elongation of spot size and/or irregular spot size for polar 
compounds using this method. The introduction of high performance TLC 
has helped this problem somewhat. The spot diameter is controlled by 
molecular diffusion in high performance plates (66). In some cases, TLC 
could be used to determine what mobile phase to use in HPLC if the same 
CSP or CMA was utilized. In the case of enantioselective synthesis, it 
could provide useful information as to the progress of a reaction. 
Theoretically, it is possible to choose the mode which best suits the 
needs of the analyst. The main obstacle to this idea has been the limited 
commercial availability of CSPs for TLC. Although there are a greater 
number of commercially available CSPs for HPLC, these columns can be 
expensive and may be easily damaged. A viable alternative to CSP is the 
use of achiral stationary phases with the appropriate CMA. Some 
disadvantages of using CMAs are: ( 1) the isolation of a pure chiral analyte 
may be difficult, and (2) the method of detection must be compatible with 
the CMA used. For example, if a compound which absorbs ultraviolet 
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light is used as a CMA, one can use an ultraviolet detector in HPLC and 
adjust the baseline accordingly but in TLC it would not be possible to 
detect the samples using an ultraviolet detector. Advantages of using CMA 
are: (1) it is easy to change the chiral selector being used, and (2) the 
lifetime of conventional achiral columns is typically longer than that of 
chiral columns. 
In this dissertation, the use of various CMAs and CSPs in TLC and 
HPLC for the resolution of chiral analytes will be discussed. A method for 
the TLC separation of enantiomers and diastereomers involving the use of 
chiral ion interaction agents will be described. Several aromatic amino 
alcohols were resolved by TLC using a mobile phase containing (1 R)-(-)-
ammonium-1 0-camphorsulfonate or N-carbobenzoxy(CBZ)-glycyl-L-
proline (ZGP). Many of these chiral aromatic amino alcohols are of 
pharmacological importance as a- and ~-adrenergic blockers, adrenergic 
compounds, and anti-glaucoma agents. A comparison was made between 
various N-CBZ-amino acid derivatives as chiral counter ions/chiral mobile 
phase additives. Various mobile phase compositions and numerous 
commercially available achiral TLC stationary phases were evaluated. 
Amino acid derivatives, nicotine derivatives and cinchona alkaloids 
were separated by thin layer chromatography on different types of 
reversed phase plates using a mobile phase containing maltosyl-~­
cyclodextrin. A comparison is made between octadecyl, diphenyl and ethyl 
reversed-phase TLC plates. Several derivatized amino acids are separated 
by thin layer chromatography utilizing hydroxypropyl-~-cyclodextrin (HP-
~-CD). Studies were conducted to determine the effect that the degree of 
substitution of HP-~-CD would have on: the resolving abilities of the 
CMA, the time of development and the viscosity of the hydroxypropyl-~-
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CD mobile phase solutions. Comparisons will be made between the native 
and the derivatized CD used as CMAs in RP-TLC. 
The separation of some drug stereoisomers using native CD CSPs and 
hydroorganic mobile phases will be presented. The principal features of 
the CD chiral recognition mechanism will be reiterated. In addition, 
several different derivatized f3-cyclodextrins were synthesized and used as 
chiral stationary phases in normal phase liquid chromatography. The 
multiply substituted derivatives were made with acetic anhydride, (R)- and 
(S)-1-(1-naphthyl)ethylisocyanate, 2,6-dimethylphenylisocyanate and p-
toluoyl chloride. The first successful cyclodextrin-based, normal phase 
separation of enantiomers was accomplished on these derivative phases. In 
contrast to chiral separations on the native ~-cyclodextrin stationary phase, 
the enantiomeric separation mechanism on these new phases in the normal 
phase mode was not thought to be dependent on inclusion complexation. 
The similarities and differences between the derivatized cyclodextrin 
stationary phases and the derivatized cellulosic stationary phases will be 
discussed. 
Analysis of free form amino acids in commercial samples and various 
physiological fluids was conducted. Detectable levels of free D-amino 
acids were found in human urine and blood serum but not in human 
amniotic fluid. This was accomplished using a liquid chromatographic 
coupled column (i.e., achiral-chiral) method that was developed for the 
rapid and sensitive analysis of these compounds. The technique was tested 
on a series of commercial L-amino acids. Care was taken to minimize 
racemization. Trace to percent levels of contaminating D-enantiomers 
were found in all commercial samples. In urine the D-amino acids ranged 
from several hundredths of a percent up to percent levels of the 
corresponding excreted natural L-amino acids. There were no apparent 
correlations between the amount of amino acids excreted and the relative 
amount of D-enantiomers present. In blood serum samples, the D-amino 
acids ranged from less than 0.05% to 0.50% levels of corresponding 
natural L-amino acids. The limit of detection for the amino acids in the 
analyzed physiological fluids was 0.05%. 
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It was possible to analyze four amino acids (phenylalanine, tyrosine, 
tryptophan and leucine) in urine. In blood serum, three out of four of the 
above-mentioned amino acids were analyzed. The majority of the 
tryptophan in the blood sample was lost during the solid phase extraction 
step. Four amino acids (phenylalanine, tyrosine, leucine and methionine) 
were analyzed in the human amniotic fluid samples. 
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II. BACKGROUND 
A. History of Chiral Separations 
Stereochemistry is that part of science which deals with structure in 
three dimensions. One aspect of stereochemistry is stereoisomerism: 
isomers which differ only in the way that the atoms are oriented in space. 
Stereoisomers which rotate plane polarized light are called optical isomers. 
In 1815 the French physicist, Jean-Baptiste Biot, found that a quartz 
rotated plane polarized light (67). This was the first report of optical 
activity. However, it was not until 1848 that the first deliberate separation 
of enantiomers from a racemic mixture was reported (68). In 1848 at the 
Ecole normale in Paris, a young chemist made a set of observations which 
led him to make a proposal that now forms the foundation of 
stereochemistry. This young man, Louis Pasteur, has just won his 
doctorate in science and he was attempting to gain some experience in 
crystallography. He was duplicating earlier work on tartaric salts when he 
noticed something no one had perceived before: optically inactive sodium 
ammonium tartrate consisted of a mixture of two distinctive types of 
crystals. Figure 2 depicts the two types of sodium ammonium tartrate 
crystals. Pasteur was able to separate the morphologically different 
crystals by hand using a hand lens and a pair of tweezers. While the 
original mixture was optically inactive, each set of crystals was found to be 
optically active in aqueous solution. Furthermore, all physical and 
chemical properties of the individual solutions were identical except the 
specific rotations of the two solutions which were equal but of opposite 
sign. Pasteur's method of mechanical separation demonstrated the 
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(+)·form (-)·form 
Sodium ammon1um tanrate 
Figure 2. Configuration of sodium ammonium tartrate crystals. Racemic 
sodium ammonium tartrate forms two sets of crystals, distinguished by the 
non-superimposable mirror-image relation of their crystal facets and the 
opposite sign of their optical activity. 
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human ability to distinguish left from right, by explicit or implicit 
reference to a chiral object, such as a hand. Thus was coined the phrase 
"right- or left-handedness". Pasteur concluded that molecular disymmetry 
was necessary for optical activity in small molecules or crystals since the 
difference in optical rotation was observed in solution. He proposed that 
the molecules composing the crystals were mirror images of each other but 
he was unable to determine why a molecule would be disymmetric or 
chiral. 
In 1874, van't Hoff and LeBel individually reported that the 
"asymmetric carbon atom" was the reason for chirality (69, 70). Van't 
Hoff elucidated the correct proposed structure, tetrahedral rather than 
square pyramidal, so he was given the lion's share of the credit for this 
discovery (See Figure 3 ). It is now known that other types of chirality 
exist. It is possible to have "chiral centers" as well as "chiral axes" and/or 
"chiral planes" of symmetry. Some examples of chiral molecules which do 
not contain "chiral centers" are shown in Figure 4. Also, organic 
molecules can contain "chiral heteroatoms" such as nitrogen or 
phosphorous. Recently it has been proposed to use the term stereogenic 
center rather than "chiral center" or "chiral atom" since, technically, an 
atom or point cannot be chiral. 
There are two different conventions for the designation of the three 
dimensional structure of a chiral entity. The first system was devised by 
Emil Fisher in his attempt to interrelate the absolute stereochemistry of 
optical isomers (71 ). In the late 1880's, Fisher arbitrarily assigned the 
absolute configuration of (+)-glucose and the Fisher projection scheme 
forms the backbone of present day carbohydrate chemistry. A Fisher 









Figure 3. Square pyramidal and tetrahedral structure 
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Figure 5. Fisher projection of D, L-glyceraldehyde 
2 I 
was honored for his groundbreaking work by becoming a Nobel Prize 
recipient. The D, L system devised by Fisher is still used to describe 
amino acids, sugars and their derivatives. 
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Another useful procedure for designating the spatial structure of 
molecules involved the use of the prefixes RandS. These prefixes were 
assigned according to a procedure devised by R. S. Cahn, Sir Christopher 
Ingold and V. Prelog. There is no essential connection relating the D, L 
and the R, S conventions. The D, L convention was based on Fisher 
projections whereas the R, S convention was based on Cahn-Ingold-Prelog 
sequence rules. 
The designation ( +) and (-) indicated the direction of specific rotation 
of plane-polarized light. If the rotation of the plane of light was to the 
right, the substance was dextrorotatory (d) or ( + ); and if the direction of 
rotation was to the left, the substance was levrorotatory (1) or (-). The 
symbols d and 1 could also be used to designate the direction of specific 
rotation. 
When Fisher reported his Nobel Prize work, there was no method for 
the determination of absolute configuration so he arbitrarily assigned his 
D, L symbols. It was not possible to answer the question of absolute 
configuration until 1951 (72). 1. M. Bijvoet reported the determination of 
the actual spatial arrangement of atoms of an optically active compound, 
d( + )-Na Rb tartrate, using x-ray crystal analysis. Luck was with Fisher for 
he had arbitrarily assigned the correct configuration for L-glyceraldehyde. 
Ever since Pasteur's pioneering work, investigators have searched for 
improved methods to resolve and purify enantiomers. There are several 
methods for resolution of enantiomers. These are: (a) conversion to 
diastereomers, (b) biochemical processes, (c) mechanical separation, (d) 
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differential reactivity, (e) selective crystallization, and (f) differential 
adsorption. The dominant approach has been conversion of enantiomers to 
diastereomers followed by crystallization. Most of these methods were 
characterized by multiple steps and low efficiency. The introduction of 
chromatography as a separation tool allowed for efficient enantiomeric 
separations. This work focuses on chiral separations that use differential 
adsorption properties of enantiomers and/or diastereomeric ion-pairs in a 
process known as chromatography. 
In 1903, the first application of differential adsorption in a flowing 
system with a mobile phase and a stationary phase to separate analytes was 
reported by Tswett (73). He passed an organic solvent solution of plant 
pigments through a glass column packed with finely divided inulin (a 
polysaccharide) and observed the formation of several sharply defined 
colored bands or zones. The pigments were separated due to differing 
abilities to adsorb upon the inulin thereby creating the colored bands noted 
by Tswett. This process was referred to as chromatography. 
Chromatography means the production of a color scheme or to write 
in colors. This technique, introduced by Tswett, is known as adsorption 
chromatography. It operates on a principle which depends upon the 
differential adsorption characteristics of analytes in a system composed of a 
solid stationary phase and a liquid mobile phase. The behavior of the 
analytes is affected primarily by the selection of solid adsorbent and 
solvent. 
In the beginning, there was only one type of chromatographic 
technique available for the scientist, this involved a polar stationary phase 
and a nonpolar mobile phase. Also, it was only possible to analyze colored 
substances. Many methods were utilized to adapt adsorption 
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chromatography to the analysis of colorless compounds. The formation of 
colored derivatives (74) and the use of dyes (75) proved successful. 
As technological advances were made in the twentieth century, 
instrumentation was developed to enhance the capabilities of 
chromatography. There are now a wide variety of commercially available 
detectors which allow detection of unlimited numbers of compounds. 
Derivatization of analytes is now used as often to enhance separation as for 
detection. Tswett used a glass column and the flow through the column 
resulted from gravitational force. Modern liquid chromatography uses 
microbore columns capable of withstanding pressures up to several 
atmospheres and mechanical pumps are used to maintain a designated flow 
rate. 
In addition to changes in technology, scientists were discovering new 
applications and methodology based on Tswett's early findings . Research 
by Martin marked the beginning of modem paper chromatography (76). 
The first gas chromatography paper appeared in 1951 (77). Stahl reported 
the first use of thin-layer chromatography five years later (78). Liquid 
chromatography emerged on a comparable basis to gas chromatography 
with the introduction of work by Huber and Hulsman (79). Halasz and 
Sebastian reported the first chemically bonded stationary phases for liquid 
chromatography (80). With the introduction of bonded stationary phases, 
it became necessary to denote the original polar stationary phase/nonpolar 
mobile phase method as the nonnal-phase mode and the newer nonpolar 
stationary phase/polar mobile phase approach as the reverse-phase mode. 
The literature contains references dating as far back as 1904 which 
catalog attempts to resolve racemic compounds using adsorption methods 
(81 ). A review of early chromatographic literature indicates that the first 
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complete resolution of enantiomers was achieved on paper 
chromatography. In 1939, Henderson and Rule reported the chiral 
separation of d, 1-p-phenylenediiminocamphor on d-lactose (82). Kotake, 
et. al., researched the influence of a chiral mobile phase on the resolution 
of several amino acids in paper chromatography in 1951 and he ascribed 
the separation to the chirality of the support, cellulose (83). In 1952, 
Dalgliesh proposed that a three-point simultaneous attachment was 
necessary to resolve amino acids using a cellulosic surface, this model was 
later modified to include additional interactions, such as repulsion and/or 
steric hindrance (84 ). Figure 6 shows a simplified model of a three-point 
interaction between chiral molecules. 
Another polysaccharide, starch, was used by Prelog et. al. to separate 
Troger's base (85) and by Krebs et. al. (86) to resolve various acids. The 
first use of a modified chromatographic support for chiral separation was 
reported in 1960 (87). Klenn and Reed impregnated silica with a 
nitroaromatic entity because such compounds were known to complex 
other aromatic hydrocarbons via 7t-1t interactions. 
In the 1960s compounds were derivatized with chiral reagents to form 
diastereomers and then chromatographically analyzed. Development of 
chiral separation techniques was dominated by gas chromatography during 
the 1960's. Gil-Av, et. a!. reported the first successful direct enantiomeric 
separation in gas chromatography in 1966 (88). This approach employed 
the differential association of enantiomers with a chiral chromatographic 
media composed of de~ivatized amino acids. Short-lived diastereomeric 
adsorbates which differ in stability were formed. The enantiomer which 
fonned the more stable complex was preferentially retained. This idea 
forms the foundation for modem chiral stationary phases and would 
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eventually lead to the development of a wide variety of chiral LC and GC 
chromatographic supports. 
In 1968 Rogozhin and Davankov (89) reported that ligand exchange 
chromatography (LEC) could be utilized for liquid chromatographic chiral 
separations. If a metal was introduced into a system which was capable of 
reversibly coordinating with an asymmetric stationary phase and the 
individual enantiomers, a complex diastereomeric specie could be 
dynamically formed (See Figure 7). Rogozhin and Davankov covalently 
bonded amino acids, such as L-proline, to a polystyrene-p-divinylbenzene 
cross-linked copolymer support and used copper (II) as the chelating metal 
to resolve free amino acid racemates. This method proved to be an 
effective technique for separating underivatized amino acids. 
A different type of complexation, inclusion complexation, was 
reported by Cram and his group (90, 91 ). Cram synthesized various chiral 
binaphthyl based crown ethers and discovered that the 18-crown-6 proved 
to be a successful chiral stationary phase (47). The chiral crown ether used 
as a CSP in this study is shown in Figure 8. It was possible to resolve 
chiral compounds which contain primary amines because the 18-crown-6 
ether moiety complexes ammonium ions (See Figure 9). 
Up to this point, progress in the field of chiral separations was moving 
at a slow pace. The 1980s marked a rapid evolutionary period for chiral 
stationary phase development and commercialization, followed by global 
public acceptance and use. The turning point was marked by the 
introduction of the 'Pirkle' bonded phase which was heralded for its wide 
applicability and became the first commercialized CSP (50). Pirkle's 
rationale in designing a chiral stationary phase was based on the theories of 











Figure 7. Simplified schematic of ternary complex formed in chiral LEC 
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interaction between the analyte and a chiral bonded molecule via 1t-1t 
interactions, hydrogen bonding, and dipolar interactions. The initial 
commercial 'Pirkle' CSP consisted of (R)-N-3,5-(dinitrobenzoyl)-
phenylglycine bonded to y-aminopropylsilanized silica gel. These CSPs can 
be used with relatively polar mobile phases, but enantioselectivity and 
stability are enhanced in the normal-phase mode. A wide variety of 1t-
complex-hydrogen bond CSPs have been sy1,1thesized by Pirkle and by 
other scientists, but the general applicability remains the same (92, 93). 
The second generation 'Pirkle' phases have improved enantioselectivity 
(37) in comparison to that of the first generation. 
In the ongoing search for new and improved CSPs, it is not surprising 
to note the continuing adaptation of saccharides as potential CSPs. Linder 
and Mannschreck reported the use of triacetyl cellulose as a CSP in 1980 
(94). Various derivatized cellulosic phases (See Figure 10) have been 
commercialized and have proven successful in separating racemic 
thioamides, sulfoxides, organophosphorus compounds, pharmaceuticals and 
amino acid derivatives. Another commercially available polysaccharide 
stationary phase was developed by Armstrong in 1984 (95). This was the 
cyclodextrin bonded phase. A simplified schematic depicting inclusion 
complexation between a solute and a native cyclodextrin stationary phase is 
shown in Figure 11. Cyclodextrin stationary phases have been utilized 
primarily in the reverse-phase mode for the resolution of pharmaceuticals, 
nicotine analogues, derivatized amino acids, steroids, metallocenes, 
binaphthyl crown ethers and various aromatic compounds. The structural 
similarities between cellulose and cyclodextrin are shown in Figure 12. 
Another type of commercially available CSP involved natural and 
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Figure 10. Cellulose derivatives utilized as chiral stationary phases 
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r-D(+ )-glucose 
Figure 12. Open chain and cyclic structures and stereochemistry of D-( + )-
glucose. Upon ring closure, a and~ anomers are formed. The a anomer 
forms cyclic molecules with a specific molecular weight; cyclodextrin. 
The J3 anomer forms linear molecules with a wide range of molecular 
weights. 
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synthetic polymer, ( + )-poly(triphenylmethyl methacrylate) as a chiral 
stationary phase ( 46). This polymer can be used either as solid high 
molecular weight polymeric particles or as soluble low molecular weight 
fractions which are adsorbed onto diphenyl silanized silica gel. The state 
of the polymer can affect the enantioselectivity and the adsorbed version 
appears to have a wider applicability. In 1983, two protein bonded LC 
phases were reported. Allenmark developed the bovine serum albumin 
(BSA) phase (48) and Hermansson produced the a1-acid glycoprotein 
(AGP) phase (49). Both of these natural polymeric phases were shown to 
be very useful. The BSA column can be utilized to separate derivatized 
amino acids, aromatic sulfoxides and certain pharmaceuticals. The AGP 
column can resolve a wide variety of cyclic and aromatic drugs. The 
major complaint for the protein bonded phases has been the frailty of these 
columns and the inability to do preparative scale separations. The second 
generation columns are proving somewhat hardier. 
It should be noted that amino acid and chiral crown ether bonded 
chiral stationary phases have been commercialized for use with ligand 
exchange chromatography and the high performance liquid 
chromatography, respectively. 
It is important to note that despite the changing face of technology, the 
basic principles of adsorption chromatography are still the same. In liquid 
chromatography (LC), the adsorption of an analyte is determined by 
several parameters: the nature of the solvent, the nature of the adsorbent, 




1. Thin layer chromatography 
Silica gel (K5F, 250 micrometer [J.lm] layer thickness, 5 x 20 
centimeter [em]), high performance silica gel (HP-KF, 200 J.lm layer 
thickness, 5 x 5 em), cellulose (K2F, 250 Jlm layer thickness, 5 x 20 em), 
chemically bonded octadecyl (KC18F, 200 J.lm layer thickness, 5 x 20 em), 
chemically bonded ethyl (KC2F, 200 J.lm layer thickness, 5 x 20 em) and 
chemically bonded diphenyl (Diphenyl-F, 250 J.lm layer thickness, 5 x 20 
em) TLC plates were obtained from Whatman Chemical Separation 
Division, Inc. (Clifton, NJ). Aluminum oxide (250 Jlm layer thickness, 5 x 
20 em) and diol (HPTLC Diol F254s, 200 j..lm layer thickness, 10 x 10 em) 
TLC plates were obtained through Alltech Associates, Inc. (Deerfield, IL). 
Phenylpropanolamine, timolol, isoproterenol, metoprolol, 
propranolol, octopamine, pindolol, N-carbobenzoxy-alanyl-L-proline, N-
carbobenzoxy-isoleucyl-L-proline, N-carbobenzoxy-L-proline, N-
carbobenzoxy-glycyl-L-proline, dansyl-DL-leucine, dansyl-DL-methionine, 
dansyl-DL-norleucine, dansyl-DL-phenylalanine, dansyl-DL-valine, 
cinchonidine, cinchonine, quinine, quinidine, heptakis (2,6-di-0-methyl)-~­
cyclodextrin, and sodium chloride were obtained from Sigma (St. Louis, 
MO). Norphenylephrine, 1-pentanol, molecular sieves (5 Angstrom, 4-8 
mesh), (1 R)-(-)-ammonium-1 0-carnphorsulfonate, DL-alanine-~­
naphthylamide, DL-methionine-~-naphthylamide and RS-5-(4-
rnethylphenyl)-5-phenylhydantoin were obtained from Aldrich 
(Milwaukee, WI). Methylene chloride (CH2CI2), ethylene glycol, 
acetonitrile, ethanol, 2-propanol, methanol (MeOH), and !-butanol were 
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obtained from Fisher Scientific (Fair Lawn, NJ). N'-(2-naphthylmethyl)-
nomicotine, a nicotine analogue, was synthesized according to the 













• i, Lithium diisopropylamide; ii, hydrochloric acid, heat, then 
hydroxide; iii, sodium cyanoborohydride; iv, n-butyllithium, then 
R2Br. 
Maltosyl-~-CD was supplied by P .C. Hermann. Two different 
companies, Pharmatec and Consortium Fur Elektrochemische Industrie 
GMBH (Wacker), supplied the HP-~-CD for the study regarding the effect 
of the degree of substitution. Pharmatec indic(!ted the degree of 
substitution (DS) as 2, 7 and 9 for their product. The average molar 
substitution (MS) of the HP-~-CD supplied by the Wacker company was 
0.6 and 0.9. The degree of substitution indicates the number of 
substitutents per CD molecule whereas the molar substitution is the number 
of substitutents per anhydroglucose unit. The ~-CD molecule consists of 
seven linked glucose units so if the MS was 0.6 for the derivatized CD; the 
OS would be 4.2. 
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2. High Performance Liquid Chromatography 
Huperzine A, a drug under investigation for Alzheimer's dementia 
(44), was kindly provided by Professor A. P. Kozikowski and Dr. Yan Xia 
of the University of Pittsburgh. SQ 30840 is a drug under investigation at 
the Squibb Institute for Medical Research, Princeton (NJ). It was supplied 
by Dr. Kimball. Efaroxan, Idazoxan and derivatives are drugs under 
investigation at Reckitt & Coleman. They were supplied by N. A. Hyde 
(Danson Lane, Kingston-upon-Hull, UK). Flouxetine is a drug under 
investigation at Eli Lilly Laboratories (Indianapolis, IN). It was provided 
by Thomas L. Jeatran. Ibuprofen was supplied by Eli Lilly. The other 
drugs were obtained as previously described (41). Etomidate and 
Norgestrel were supplied by Advanced Separations Technologies 
(Whippany, NJ). Methanol and acetonitrile were from Fisher Scientific 
(Fair Lawn, NJ). 
The structures of the solutes, which were obtained from various 
sources, are presented in the tables. Hexane and isopropanol were obtained 
from Fisher Scientific (St. Louis, MO). 
Dinitrobenzoyl chloride, 2,6-dimethylphenylisocyanate, (R) and (S)-1-
(1-naphthyl)ethylisocyanate and p-toluoyl chloride were obtained from 
Aldrich Chemical Company (Milwaukee, WI). The acetylated (3-CD 
column was 250 x 4.6 mm column obtained from Advanced Separation 
Technologies, Inc. (Whippany, NJ). The chromatographic columns used in 
the normal phase HPLC study were synthesized according to the procedure 
listed under preparation of bonded phase. The columns were packed by 
Tom Beesley at Advanced Separations Technologies, Inc. (Whippany, NJ). 
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The perchloric acid, mercaptoethanol, boric acid, o-phthalaldehyde, 
and DL-amino acids were obtained from Aldrich (Milwaukee, WI). 
Methanol, ethanol and potassium hydroxide were supplied by Fisher (St. 
Louis, MO). The L-amino acids were provided by the following 
companies: Kodak (Rochester, NY), Lancaster Synthesis (Windham, NJ), 
Fluka (Ronkonkoma, NY), Sigma (St. Louis, MO), Spectrum (Gardena, 
CA) and Research Plus, Inc. (Bayonne, NJ). All of the samples and mobile 
phase solutions were filtered using 0.2 fJ. filters supplied by Alltech 
Associates, Inc. (Deerfield, IL). 
The chromatographic system was a Shimadzu Gradient System, with 
two LC-6A pumps, a SCL-6A gradient controller, and a UV detector, 
model SPD-6A. The recorder was the Shimadzu model C-R2AX 
integrator. The column dimensions were 25 em x 4.6 mm, i.d. Cyclobond 
I bonded with ~-cyclodextrin (seven glucopyranoside units) from Astec. A 
Cyclobond II column bonded with y-cyclodextrin (eight glucopyranoside 
units) was also used. 
The chromatographic columns used in the urine, blood and amniotic 
fluid studies included the Crownpak CR( +) and CR(-) columns supplied by 
Michael Henry at J.T. Baker (Phillipsburg, NJ) and 5 fJ. octadecylsilane 
(CI8) columns obtained from Advanced Separation Technology 
(Whippany, NJ). 
The LC system used for the analysis of commercial sources of L-
amino acids consisted of a Shimadzu LC-6A pump and CR3A chromatopac 
recorder, an ESA (Bedford, MA) Coulochem model 51 OOA detector and 
analytical cell model 5011, and a Rheodyne (Cotati, CA) model 7125 
injector. Two different chromatographic systems were used for the urine 
study. The electrochemical (LCEC) system consisted of two Rheodyne 
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injectors (models 7125 and 7010), two Shimadzu LC-6A pumps, a Perkin 
Elmer (Norwalk, CT) LC-85B spectrophotometric detector, the above-
mentioned ESA electrochemical detection system, a Perkin Elmer R100A 
recorder and a Shimadzu CR3A Chromatopac recorder. The LC system 
which utilized fluorescence detection was made up of the following 
Shimadzu devices: two LC-6A pumps, a SCL-6B system controller, a 
CR601 chromatopac recorder, SPD-6AV UVNIS spectrophotometric 
detector, and a RF-535 fluorescence HPLC monitor. The "fluorescence" 
chromatographic system also included a Rainin (San Carlos, CA) model A-
30-S pump, a Scientific Systems, Inc. (State College, P A) pulse dampener 
model LP-21 and two Rheodyne injectors (models 7125 and 7010) for post 
column derivatization. 
A Labconco (Kansas City, MO) Freeze Dryer model 75018 was used 
to concentrate some samples and a Precision Clinical Centricone 
manufactured by Precision Scientific Company (Chicago, IL) was used for 
centrifugation. 
B. METHODS 
1. Normal phase TLC 
The molecular sieves (Type 5A) were dried for twenty four hours at 
three hundred and fifty degrees centigrade and stored in a drying oven at 
one hundred and twenty five degrees centigrade. Fifty grams of molecular 
sieves were used to dry two hundred and fifty milliliters of solvent. The 
solvents were dryed for twenty four hours before use. The TLC plates 
were placed in a drying oven at one hundred and twenty five degrees 
centigrade for three to four hours and then stored in a dessicator until use. 
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It took approximately thirty to forty-five minutes to completely 
develop a 5 x 5 em TLC plate. All developments were done at room 
temperature (200c) in 6 em internal diameter (i.d.) x 23 em cylindrical 
glass chambers. Spot visualization was performed by use of a fixed 
wavelength, 254 nm, ultraviolet (UV) lamp. A Schimadzu dual wavelength 
TLC scanner (CS-910) was used to measure resolution. Various 
wavelengths were scanned to provide supporting evidence as to the validity 
of the enantiomeric separation. 
2. Reverse phase TLC 
Sodium chloride was used to stabilize the plate binder. 0.6M sodium 
chloride was added to the mobile phases containing greater than 50% water 
by volume. Acetonitrile and methanol were used as organic modifiers. 
The plates were developed at room temperature (200c) in 6 (i.d.) x 23 
em cylindrical glass chambers. Spot visualization was performed by use of 
a fixed wavelength (254 nm) ultraviolet lamp. A Shimadzu dual 
wavelength TLC scanner (CS-910) was used to measure resolution in the 
HP-(3-CD study. 
It took approximately thirty-six to forty-eight hours to completely 
develop a 5 x 20 em TLC plate when maltosyl-(3-CD was the CMA. It took 
approximately thirty minutes to completely develop a 5 x 20 em TLC plate 
when the CMA was dimethyl-(3-CD. The approximate development times 
are discussed in the results section for the data obtained when HP-(3-CD 
was the CMA. 
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3. Amino Acid Study 
Prior to using the LCEC systems, voltage scans were run on several 
essential amino acids. The following amino acids were chosen for the 
LCEC commercial study: cysteine, methionine, ornithine, tryptophan and 
tyrosine. The applied voltage for the analysis of cysteine, methionine, 
tyrosine, and tryptophan was +0.5 volts. A somewhat better response was 
noted for these compounds if the voltage was greater than +0.5 and less 
than +0.8 volts but the background current was considered to be too high 
(greater than 1 J.l amp). A high background current can have detrimental 
effects on the electrodes. Ornithine was analyzed at -0.10 volts. 
Before beginning this study, it was necessary to optimize the 
separation of enantiomers by modifying the mobile phase conditions, the 
flow rate and the column temperature. Cysteine and ornithine elute rather 
quickly so the optimum temperature was determined to be ooc and 10°C, 
respectively. The optimum flow rate for these two amino acids was 0.1 
ml/min. The mobile phase composition was aqueous perchloric acid (pH = 
1.5 or 2.0). Under the stated conditions, it was possible to quantitate the 
amount of D-amino acid present without interference from the void 
volume peak. Methionine, tryptophan, phenylalanine, and tyrosine had 
longer retention times so it was possible to analyze these amino acids at 
room temperature. The flow rate for methionine and tyrosine was 0.3 
ml/min; for phenylalanine, 0.5 ml/min; and the flow rate for tryptophan 
was 0.8 ml/min. The mobile phase composition was 97.5/2.5 aqueous 
perchloric acid/methanol (v/v) or 100% pH=2 HCl04 solution for these 
three compounds. 
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A C 18 column was used to isolate the individual amino acids. The 
mobile phase consisted either of 95:5 water:methanol (v:v) or 95:5, 5xl0-3 
M HCl04:methanol (v:v). The flow rate was 1.0 or 1.5 ml/min. The 
column was at room temperature and the UV detector setting was at 200 
nm. 
A column switching or coupled column method was used for the 
analysis of tyrosine, phenylalanine, tryptophan and leucine in physiological 
fluids (Figure 26). Urine specimens taken in the early morning were 
preferred as they contained higher overall amino acid concentrations. The 
optimum separation conditions for the chiral separation are as listed above 
and in the individual figures. 
Two different methods of detection were used in the urine study: 
electrochemical and fluorescence. The applied voltages for the LCEC 
experiments were the same as those listed above. Post column OP A 
derivatization of the amino acids was required for fluorescence detection. 
The excitation wavelength was 340 nm and the emission wavelength was 
450 nm. The Rainin pump was the post column pump for this system. The 
OP A solution was prepared as follows. The OPA reagent was prepared by 
dissolving 700 mg of o-phthalaldehyde in 15 ml of ethanol. Three hundred 
milliliters of mercaptoethanol was added to this solution. The solution was 
then added to lliter of 3% boric acid solution which had been adjusted to 
pH=lO.O with KOH. Teflon tubing (0.5 millimeters i.d.) was used with the 
post column apparatus and the post column reactor was 3 meters long. 
C. PREPARATION OF DERIVATIZED CD BONDED PHASE 
~-Cyclodextrin was attached to 5 ll spherical silica as previously 
reported (96). Four grams of the ~-CD bonded phase were dried 
overnight under vacuum in a drying gun using MeOH and P205. The 
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dried sorbent was placed in a 3-necked round bottom flask. Anhydrous 
solvent (Aldrich) (100 mL) was added. Pyridine was used as the solvent 
for the isocyanate derivatized phases and toluene ( + 3 mL pyridine) was 
used for the acid chloride derivatized phase. The mixture was refluxed 
until all the water was removed (as an azeotrope into a Dean-Stark trap). 
The derivatizing agent was added (neat) and the mixture was refluxed for 
about four hours (three hours for the acid chloride derivatized phase). The 
isocyanate derivatized ~-CD bonded phases were collected on a fritted glass 
filter and washed with approximately 100 mL of pyridine followed by 200 
mL of MeOH and then air dried. The acid chloride derivatized ~-CD 
phase was also collected on a fritted glass filter and washed with 
approximately 100 mL each of pyridine and MeOH, about 10 mL of H20 
followed by MeOH and then air dried. 
The bonded sorbents were submitted for carbon analysis. The surface 
concentration was calculated according to the equation (97). 
(Jlmoles/m2) = %C x 106 
S[1200Nc- %C(M- 1)] 
where Nc is the number of carbons in the ligand, M is the molecular 
weight of the ligand and S is the surface area of the substrate, which, 
according to the manufacturer, is 170 m2fg. For ~-CD (Nc = 42, M = 
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1135), the coverage was calculated to be 0.20 J.Lmoles/m2. To determine 
the degree of substitution on the ~-CD of the derivatized ~-CD phases, the 
%C from the CD+ linkage chain was subtracted from the total %C and 
M - 1 was substituted by M in the denominator. The degree of substitution 
for each of the phases were calculated and are reported in Table I. The 
sorbents were all packed into 250 x 4.6 mm stainless steel columns. 
D. SAMPLE PREPARATION 
1. Urinalysis 
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All samples were dissolved in the mobile phase solution immediately 
prior to analysis. The results of this study were reproducible if the column 
and the detector current were allowed to stabilize before beginning the 
analysis. The average concentration of the L-amino acids was 10 mM. 
Despite the large amount of sample injected, it was still possible to attain 
baseline resolution with a single column. When using fluorescence 
detection the average concentration of the L-amino acid standard solution 
was 0.2 mM. 
Urine samples were collected from young healthy adults. The mobile 
phase solution and the urine samples were filtered with 0.2 Jl filters. If the 
urine appeared cloudy, the sample was centrifuged at 1550 rpm for 5 
minutes. The supernatant was filtered and analyzed. All remaining urine 
samples were refrigerated at 4 °C. 
In one set of experiments the samples were concentrated by freeze 
drying. The freeze-dried samples were dissolved in the mobile phase 
solution immediately prior to analysis. 
2. Blood serum analysis 
Venous blood was collected from young healthy adults. The blood 
samples were placed in a refrigerator for twenty-four hours to allow 
coagulation. The samples were centrifuged at 1550 rpm for fifteen 
minutes. The supematent was collected and filtered with a 0.2Jl filter. 
Solid phase extraction (SPE) was performed to remove proteins. A C18 
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SPE cartidge was utilized. The cartridge was washed with 2 x 2 milliliters 
(mL) of MeOH and H20, respectively. Two to three mL of sample was 
introduced onto the cartridge. The sample was eluted using one mL of 
aqueous perchloric acid (pH=2.0). Thi_s sample was immediately analyzed 
using a coupled column system. 
In one set of experiments the samples were concentrated by freeze 
drying. The freeze-dried samples were dissolved in the mobile phase 
solution immediately prior to analysis. 
3. Amniotic fluid analysis 
Frozen amniotic fluid samples were graciously donated by Dr. Sau W. 
Cheung, Ph. D at Washington University School of Medicine. These 
samples were collected from pregnant women and stored in a freezer at 40 
C until analysis. The age of the samples ranged from several days to 
several years . 
The amniotic fluid samples were thawed for five to ten minutes at 
room temperature. The samples were filtered with a 0.2J.l filter and 
analyzed using a coupled column system. 
In one set of experiments the samples were concentrated by freeze 
drying. The freeze-dried samples were dissolved in the mobile phase 
solution immediately prior to analysis. 
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IV. RESULTS AND DISCUSSION 
A. CHIRAL COUNTER IONS IN NORMAL PHASE TLC 
A method was developed for the thin layer chromatographic (TLC) 
separation of enantiomers and diastereomers involving the use of chiral ion 
interaction agents based on prior normal-phase HPLC studies (26-28). 
Several aromatic amino alcohols were resolved by TLC on diol and/or high 
performance silica gel plates using a mobile phase containing (lR)-(-)-
ammonium-! 0-camphorsulfonate (CSA) or N-carbobenzoxy-glycyl-L-
proline (ZGP). Results which were attained using ZGP or CSA as chiral 
mobile phase additives in TLC are similar to those obtained using the same 
CMAs in HPLC. One major difference was that separations of aromatic 
amino alcohols in HPLC involved the ( +) antipode of 1 0-camphorsulfonate 
whereas the same work performed in TLC used the (-) antipode. The 
chiral separation mechanism for each chromatographic method (HPLC and 
TLC) was the formation of diastereomeric ion-pairs. 
For the TLC studies as well as the HPLC studies, no enantiomeric 
separations could be achieved with any of the ion interaction agents unless 
the solvents and the chromatographic bed were thoroughly dried. 
Presumably, this was because an intimate, multi-point interaction must 
occur between the chiral ion interaction agent and the racemic substrate. 
Hydrogen bonding is particularly important when these associations occur 
(7t-7t interactions, dipole-dipole interactions and steric interactions are also 
pertinent). If too much water is present, the water may preferentially 
associate via hydrogen bonding with the chiral selector and/or racemate 
thereby negating interactions between these species that are important for 
chiral recognition. 
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Dichloromethane was the major component of the mobile phase. 
However, it was difficult to dissolve ammonium camphorsulfonate (CSA) 
in dry dichloromethane. Several organic co-solvents were tested to 
evaluate their ability to solubilize CSA. These solvents included: 1-
pentanol, 1-butanol, 2-propanol, ethanol, methanol, acetonitrile, and 
ethylene glycol. CSA was most soluble if ethylene glycol was used but the 
solution appeared to form two layers and thus was impractical. CSA was 
soluble in solutions which contained the lower molecular weight alcohols. 
As was expected, the higher the percent of alcohol in the mobile phase, the 
greater the solubility of the chiral ion interaction agent. It was possible to 
attain resolution of metoprolol at 95/5 (v/v) dichloromethane/methanol 
although CSA displayed limited solubility in mobile phases which contained 
less than 10% alcohol by volume. The best results were obtained when dry 
methanol or 2-propanol were present in the mobile phase. 
No solubility problem was encountered with these mixed mobile 
phases when using ZG P as a chiral mobile phase additive, so it was possible 
to study the effects of different CMA concentrations. In this study, the 
concentration of ZGP was varied from 6.5-16.8 mM without any 
significant change in the retention factor (Rf) or the separation factor (a) 
(Table 1). The capacity factors (k') for the enantiomers usually decrease 
with an increase in the concentration of the counter ion. This is probably 
due to increased competition between the counter ion and the 
diastereomeric ion-pair for adsorption sites on the stationary phase. 
Separations obtained on silica gel (K5F) and high performance silica 
gel (HP-KF) gave approximately the same Rf values but the K5F did not 
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Table I. Effect of Varying Concentration of ZGP 
on Enantioselectivity for Propranolol in TLC Study 
Concentration of a 
ZGP (mM) 
6.5 0.07 0.23 1.7 
6.8 0.07 0.14 1.9 
13.6 0.06 0.21 1.8 
16.8 0.08 0.20 1.6 
*Experimental conditions: The mobile phase consisted of 90/10, methylene 
chloride/methanol. The stationary phase was HP-KF silica gel. The 
method of detection was a Schimadzu dual wavelength TLC scanner (CS-
910). 
offer the same selectivity as HP-KF. Separations on the ethyl (KC2F) 
plates gave higher Rf values than the HP-KF plates but no enantiomers 
5 1 
were resolved on the KC2F plates. The ethyl and diol plates gave similar 
Rf values except there was much greater streaking on the ethyl plates. 
There was very little spot movement on either the aluminum oxide plates 
or the cellulosic plates. The only TLC plates on which effective, 
reproducible enantiomeric separations could be obtained were the diol and 
the high perfonnance silica gel plates (HP-KF). 
The structures of the resolved compounds as well as pertinent separation 
data are given in Table II. Note that all of the compounds have three 
functionalities in common: an aromatic ring, an a-hydroxyl group and a 
~-amine. Table II shows that it was possible to achieve very efficient 
separations with the use of CSA and ZGP as chiral mobile phase additives 
(CMAs). Several compounds were separated with both CMAs. In four out 
of five of these compounds (Table II) a higher selectivity was obtained by 
adding 5 mM triethylamine (TEA) when ZGP was the CMA. A majority 
of the racemates were resolved on the HP-KF plates. Retention on the 
stationary phases was due to the OH-groups present on both the HP silica 
gel and the diol plates. These types of plates displayed a certain similarity 
in their chromatographic behavior, however the silica gel plates were more 
strongly adsorbing than the diol plates (98). Note that the mobile phase 
which was used in conjunction with the diol plates had a lower percentage 
of alcohol and used a less polar alcohol in comparison with the mobile 
phases used with the HP silica gel plates. There were two similarities 
among the compounds resolved with the diol plates: none of these 
compounds contained a primary amine and each racemate had a terminal 
branched hydrocarbon group. The separations achieved on the diol plates 
Table IT. Compounds Separated Using ZGP or CSA as 
Chiral Mobile Phase Additives 
Enantiomers Rn Rf2 a Conditions 
Octopamine 0.15 0.33 2.2 7.9mMCSAa 
HOCHOi1NH, $ 
OH 





Norphenylephrine 0.05 0.26 5.2 5.9mM zapa 
OIOi~ 
~6.. 0.03 0.14 4.7 6.8mMCSAC 
OH 
Propranolol 0.08 0.20 2.5 6.7 mM ZGPC 
0.05 0.20 4.0 9.3 mM CSAC 
Isoproterenol 0.14 0.38 2.7 5.9 mM zapa 
0.12 0.30 2.5 6.8 mM CSAa 
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Metoprolol 0.11 0.17 1.5 10.7mMCSAb 
OI,OCHtOit -@-OCHt~:NHCH(OiJh 




13.9mMCSAb 0~ OO!t<fHO!tNHC(Oi,), 0.39 0.55 1.4 
OK 
Diastereomers 
Labetalol 0.01 0.05 5.0 6.7 mM ZGPb 
0.05 2.5 9.3 mM CSAb 






Pheny !propanol- 0.06 0.26 4.3 6.9mMZGPa 
anune 
HOOIO!Ol3 @NH, 
a HP Silica gel plates with 75/25 (v/v) methylene chloride/methanol 
b DIOL plates with 95/5 (v/v) methylene chloride/2-propanol 
c HP Silica gel plates with 90/10 (v/v) methylene chloride/methanol 
NOTE: All separations achieved with ZGP contained 5 mM TEA. 
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gave lower a values than those attained with the HP-KF plates. None of 
the adrenergic compounds were resolved on the dial plates. Separations 
were optimized for most of the adrenergic compounds by using a higher 
alcohol content in the mobile phase whereas most of the separations for the 
~-adrenergic blockers were optimized with a lower percentage alcohol 
content and/or a less polar alcohol in the mobile phase. 
Figure 13 shows two TLC chromatograms. These chromatograms 
illustrate the high degree of stereoselectivity obtainable with this method. 
Both chromatograms were developed on HP-KF plates using 75:25 (v/v) 
dichloromethane/methanol but each used a different CMA. The plate on 
the left illustrates the separation of isoproterenol and propranolol using 
CSA as a chiral ion interaction· agent. The plate on the rightt shows the 
resolution of methoxamine, norphenylephrine, phenylpropranolamine and 
octopamine employing ZGP and triethylamine (TEA). Methoxamine and 
phenylpropranolamine have two stereogenic centers so there are four 
stereoisomers for each compound. The number of stereoisomers is 
determined by application of the 2n rule were n = the number of 
stereogenic centers for the compound. The TLC densitometric scans for 
the above-mentioned plate showed three peaks for methoxamine and two 
peaks for phenylpropranolamine. The resolution of methoxamine was not 
reported under these conditions because it was not possible to determine 
which stereoisomers were resolved. The separation of 
phenylpropanolamine was presumed to be between diastereomers rather 
than between enantiomers. 
Figures 14 and 15 show three TLC densitometric profiles of TLC 












no'rph ' o~tap 
methox ph-pro 
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Figure 13: Thin layer chromatograms on 5 x 5 em HPTLC silica gel. (A) 
Mobile phase 75:25 CH2Cl2: MeOH containing 6.8 mM camphorsulfonic 
acid (CSA). isopr (isoproterenol); propra (propranolol). (B) Mobile 
phase 75:25 CH2Cl2: MeOH containing 6.9 mM N-carbobenzoxy-glycyl-L-
proline (ZGP) and 5 mM triethylamine. methox (methoxamine); norph 
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Figure 14: TLC densitometric scans (using a Shimadzu CS-910 at three 
different wavelengths) showing the resolution of racemic 
norphenylephrine. The stationary phase was a HPTLC silica gel plate (5x5 
em). The mobile phase consisted of 6.6 mM N-CBZ-gly-L-proline + 5 
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Figure 15: TLC densitometric scans (using a Shimadzu CS-910 scanner) 
showing the resolution of racemic isoproterenol (a bronchodilator). The 
stationary phase was a HPTLC silica gel plate (5x5 em). The mobile phase 
consisted of 6.8 mM camphorsulfonic acid dissolved in 75:25 (v/v) 
CH2CI2: MeOH. 
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the peak areas maintain the same relative proportions at different 
wavelengths thereby making it possible that these were enantiomeric 
separations. The stationary phase was HP silica gel and the mobile phase 
was 75:25 (v/v) dichloromethane/methanol for both separations. In Figure 
14, norphenylephrine was resolved using ZGP and TEA. Figure 15 
illustrates the resolution of racemic isoproterenol; the chiral ion 
interaction agent was CSA. 
A comparison was made between various N -CBZ-amino acid 
derivatives as CMAs: N-CBZ-alanyl-L-proline (ZAP), N-CBZ-isoleucyl-
L-proline (ZIP), N-CBZ-L-proline (ZP) and N-CBZ-glycyl-L-proline 
(ZG P). Table III shows that it was possible to attain some separations with 
all of the N -CBZ-amino acid derivatives. However, ZGP separated the 
largest number of compounds and gave higher a values than the other N-
CBZ-amino acid derivatives. Note that the only compound resolved using 
diol plates and 2- propanol with an N -CBZ derivative was metoprolol. 
Also, metoprolol was the only compound resolved using ZAP or ZP as a 
CMA. It was possible to separate two adrenergic compounds and one~­
adrenergic blocker using ZIP as a CMA (Table III). From these results it 
was clear that ZGP was the best chiral ion interaction agent of the N-CBZ-
amino acid derivatives in resolving the racemates of interest in this study. 
In thin layer chromatography, ZGP and CSA demonstrated unique 
abilities in separating enantiomeric amino alcohols. Of the ten pairs of 
enantiomers resolved in this TLC study; two compounds could only be 
separated using ZGP, three compounds could only be resolved using CSA 
and five of the compounds analyzed could be separated using either CMA. 
Of the enantiomers which could be resolved with either CMA, a higher 
stereoselectivity was obtained in four out of five of these compounds 
Table III. Compounds Separated Using Other N-
CBZ Amino Acid Derivatives as CMAs. 
Compounds Rn Rf2 a 
N orphen y lephrine 0.20 0.48 2.4 
Octopamine 0.20 0.52 2.6 
Metoprolol 0.17 0.28 1.6 
0.17 0.28 1.6 
0.17 0.28 1.6 
Propranolol 0.10 0.30 3.0 
Isoproterenol 0.04 0.10 2.5 
Phenylpropanolamine 0.08 0.32 4.0 
Timolol 0.20 0.40 2.0 
aHP Silica Gel Plates with 75/25 CH2Cl2/MeOH 






7.5 mM ZIPa 
7.5 mM ZIPa 
6.9 mM ZIPb 
7.0 mM ZAPb 
7.8 mM zpb 
6.3 mM ZGPa 
6.3 mM ZGPa 
6.3 mM ZGPa 
5.8 mM ZGPa 
NOTE: The TEA was not used as an additive for these separations. 
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(Table II) when ZGP was the CMA. It was possible to obtain better 
stereoselectivity in HPLC with ZGP than with CSA for the amino alcohols 
analyzed (99). In HPLC, the preferred stationary phase was the DIOL. In 
TLC, the largest number of compounds were separated with the high 
perfonnance silica gel plates although it was necessary to use the DIOL 
plates to resolve some of the analytes. The only compound which could be 
separated on either type of TLC plate was timolol. 
There were several mobile phase dissimilarities which could be noted 
in a comparison between HPLC and TLC when ZGP and CSA are used as 
CMAs. The addition of triethylamine (TEA) to the mobile phase in HPLC 
decreased retention times but did not effect stereoselectivity. The use of 
TEA in the mobile phase in TLC gave different results with different 
compounds (Table IV) and no general trend was noted. Acetonitrile, 
tetrahydrofuran, 1-pentanol and ethyl acetate could be used as polar 
modifiers in HPLC but 1-pentanol was the only modifier which did not 
contribute to peak asymmetry. Solute movement in TLC was restricted to 
mobile phases which contained an alcohol as co-solvent. The Rf values in 
TLC increased with an increase in the amount of alcohol in the mobile 
phase. This is expected because the solutes travel farther on the plate if 
interactions with the mobile phase are enhanced. Conversely, an increase 
in the alcohol content resulted in decreased retention times in HPLC. If 
mobile phase interactions are enhanced in HPLC, the solute elutes from the 
column faster. The a values changed, in TLC, if the amount of alcohol in 
the mobile phase was varied. 
This approach was highly successful in separating chiral aromatic 
amino alcohols. Once the separation was optimized, it was possible to 
attain enantiomeric separations with good a values in approximately 30 
6 I 
Table IV. The Effect on Enantioselectivity when 
TEA is added to Mobile Phases Containing ZGP in 
TLC Studies 
Compound with TEA without TEA 
Rf1 Rf2 a a 
Isoproterenol 0.14 0.38 2.7 0.04 0.10 2.5 
Phenylpropranol- 0.06 0.26 4.3 0.08 0.32 4.0 
am me 
Timolol 0.26 0.51 2.0 0.20 0.40 2.0 
Norphenylephrine 0.05 0.26 5.2 0.05 0.26 5.2 
Propranolol 0.08 0.20 2.5 0.10 0.30 3.0 
*Experimental conditions: The mobile phase consisted of 75/25, methylene 
chloride/methanol. The stationary phase was HP-KF silica gel. A 
Schimadzu dual wavelength TLC scanner(CS-910) was used for detection. 
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minutes. This appeared to be a good method for screening specific types of 
racemic compounds and different solvent systems for HPLC in a relatively 
short time. Many of these chiral ion interaction agents were relatively 
inexpensive and provided an easily accessible pathway for enantiomeric 
separations, but the supply of CSPs for TLC remains limited. 
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B. CHIRAL MOBILE PHASE ADDITIVES IN REVERSE PHASE TLC 
Recent investigations into the use of COs as chiral separation agents 
involved the utilization of different types of cyclodextrin derivatives as 
CMA in reverse-phase media. Derivatization of some of the CD hydroxyls 
resulted in enhanced aqueous solubility relative to the native CD (32). 
Similar mobile phases were used for the native and derivatized 
cyclodextrins. Some compounds, such as dansyl amino acids, could be 
separated using either the native or the derivatized CD. 
For the maltosyl-~-CD study, three types of reversed-phase TLC 
plates were used: octadecyl, diphenyl, and ethyl. Table V contains data 
and conditions for compounds separated using maltosyl-~-CD as a CMA. 
Separations were achieved for the dansyl amino acids on all three types of 
plates. The best separation for dansyl leucine was obtained using the 
octadecyl plates whereas the best results for dansyl valine were obtained 
with the ethyl plates. The separation factors (a) obtained with the dansyl 
amino acids showed little variance between the plate types indicating that 
the plates affected efficiency more than selectivity. It was possible to 
separate the diastereomers, quinine and quinidine, with all plate types as 
well. The separation factor (a) was the same for the ethyl and diphenyl 
plates but the a value achieved with the octadecyl plates was much lower. 
The preferred TLC plate was the ethyl (KC2F) because a greater number 
of compounds were separated using this plate type. Note that in all cases 
the mobile phase consisted of an acetonitrile-water mixture with a 
derivatized ~-cyclodextrin as the CMA. The best results were obtained 
with 30no (v/v) acetonitrile-water mixtures and 0.4 M maltosyl-~-CD. 
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Table V. Compounds Separated Using Maltosyl ~­
Cyclodextrin as CMA 
Reversed 
Phase 
Enantiomers Rn Rf2 !! Plate Type 
(1) DL-Alanine-~-naphthylamide 0.71 0.66 1.08 ethyl 
(2) Dansyl DL-leucine 0.22 0.16 1.38 octadecyl 
(3) Dansyl DL-valine 0.40 0.31 1.29 diphenyl 
(4) DL-Methionine-~-naphthylamide 0.39 0.34 1.15 ethyl 
(5) N'-(2-N aphthylmethyl)nomicotine 0.50 0.30 1.67 ethyl 
Diastereomers 
(1) Cinchonidine/Cinchonine 0.23 0.12 1.92 ethyl 
(2) Quinidine/Quinine 0.09 0.03 3.00 ethyl* 
*Analysis using diphenyl plate produced the same value for selectivity (a). 
The mobile phase consists of: 30/70, acetonitrile/water which contains 
0.4 M maltosyl-~-CD and 0.6 M NaCl. 
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When greater than 30% acetonitrile was added, some streaking occurred 
and most of the solutes traveled with the solvent front. There was more 
streaking and no separations were achieved when methanol was used as an 
organic modifier. The minimum concentration of maltosyl-(3-CD required 
for a chiral separation was 0.4 M. 
The retention behavior of the the amino acid derivatives was the same 
as observed in prior studies (30). In Figure 16, the D enantiomer elutes 
ahead of the L enantiomer because the chiral agent is in the mobile phase. 
A reversal of the retention behavior is seen if the chiral agent is bonded to 
the stationary phase exclusively. 
All of the compounds in Table V contain a naphthyl group or two 
fused aromatic rings. The size of the internal diameter of (3-CD is 
approximately the size of a naphthyl moiety. There is a relatively "tight 
fit" for molecules with two or more rings which are complexed by (3-CD 
(41). It is believed that chiral recognition is enhanced if the conformation 
and movement of the complexed solute is restricted inside the CD cavity 
( 1 00). The largest separation factors indicated in Table V were for 
compounds which had the chiral center located between two aromatic ring 
systems, e.g.-N'-(2-naphthylmethyl)nomicotine, quinidine/quinine and 
cinchonidine/cinchonine. This was in agreement with prior work which 
indicated that enantioselectivity was enhanced when a chiral center was 
"sandwiched" between two 1t systems (101). This enhancement was 
believed to be due to the rigidity of the chiral molecule and the fact that the 
chiral center appeared to be the main point at which rotation can occur 
between the two 1t systems. In addition, diastereomers have different 
chemical properties and one would expect to see larger separation values 
for the cinchona alkaloids. 
-A 
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Figure 16. Reversed phase TLC chromatograms showing the separation of 
enantiomers (A) dansyl D,L-valine; dansyl D,L leucine; D,L-alanine-f3-
naphthylamide and racemic N'-(2-naphthylmethyl)nomicotine. 
Chromatogram (B) shows a typical separation of the indicated diastereomers. 
The mobile phase consists of: 3ono acetonitrile/water which contains 0.4 M 
maltosyl-f3-CD and 0.6 M NaCl. 
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No separations were obtained using dimethyl-P-CD as a CMA. The 
range of CMA concentration was 0.4- 1 x 10-3 M. The organic modifier 
used was acetonitrile. Due to the scarcity of available planar 
chromatographic techniques for resolving enantiomers, the use of 
substituted COs as CMAs in reverse-phase media remains a viable 
alternative to CSPs. 
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C. TLC STUDY OF THE EFFECT OF THE DEGREE OF 
SUBSTITUTION OF HYDROXYPROPYL-~-CYCLODEXTRIN 
Several derivatized amino acids were separated by thin layer 
chromatography (TLC) utilizing hydroxypropyl-f3-cyclodextrin (HP-f3-
CD). Studies were conducted to determine the effect that the degree of 
substitution of HP-f3-CD would have on: the resolving abilities of the 
CMA, the time of development and the viscosity of the hydroxypropyl-f3-
CD mobile phase solutions. Unfortunately, maltosyl derivatized f3-CD 
having different degrees of substitution was unavailable. 
Table VI contains viscosity data (in centiposes) and development times 
(in hours) for the HP-f3-CD solutions which were used in this study. Two 
mobile phase compositions were used in this study. As seen in Table VI, 
the viscosity of the solutions increased and the % plate traversed decreased 
as the number of substitutents per CD molecule increased. The % plate 
traversed indicated how far the solvent front traveled during development 
relative to the length of the plate. The experiment (i.e., plate development) 
was stopped when the solvent front ceased movement. The % plate 
traversed increased and the development time decreased if the top of the 
development chamber was covered in parafilm rather than a small glass 
beaker. The parafilm formed a better seal on the container thereby 
preventing the loss of vapor. 
Table VII contains separation data for several enantiomeric and 
diastereomeric compounds. Figures 17 and 18 show the separation of 
stereoisomers using hydroxypropyl-f3-cyclodextrin supplied by Wacker and 
Phannatec, respectively. It was important to note that the best separations 
for all of the analytes were obtained using the CMA with the lowest 
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Table VI. Viscosity Data (f.!) and Development Times (T d) for 
Hydroxypropyi-~-CD Derivatives Study 
CD Derivative bl1 (cp) T d 1 (hrs) % plate developed 







































f.ll and T d 1 are values obtained using solution 1. The mobile phase in 
solution 1 consisted of: 30/70 (v/v) acetonitrile/water which contained 0.4 
M HP-~-CD and 0.6 M NaCI. 
f.l2 and T d2 are values for solution 2. The mobile phase in solution 2 
consists of: 35/65 (v/v) acetonitrile/water which contained 0.3 M HP-~-CD 
and 0.6 M NaCI. 
The top of the TLC development chamber was covered in parafilm. 
Pharmatec indicated the degree of substitution (DS) of the CD 
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Figure 17. Reversed-phase TLC chromatograms showing the separation of 
enantiomers (A) and (B) dansyl DL-leucine; dansyl DL-methionine; dansyl 
DL-norleucine; dansyl DL-phenylalanine and dansyl DL-valine. The mobile 
phase consists of: 30no acetonitrile/water which contains 0.4 M HP-P-CD 
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Figure 18. Reversed-phase TLC chromatograms showing the separation of 
enantiomers and diastereomers(A),(B), and (C) cinchonine/cinchonidine; 
methionine-(3-naphthylamide; 5-(4-methylphenyl)-5-phenylhydantoin and 
quinine/quinidine. The conditions for each chromatogram was the same 
except the degree of substitution of the CMA. The mobile phase consists of: 
35/65 acetonitrile/water which contains 0.3 M HP-(3-CD (Phannatec) and 
0.6 M NaCl. The stationary phase was octadecylsilane. 
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number of substitutents. The general trend was that the separation factor 
(a) decreased as the degree of substitution (or the molar substitution) 
increased. This held true for all enantiomeric separations. The only 
exceptions noted were with the diastereomeric separations where the a 
value was larger if the OS of the CMA was nine rather than seven. Since 
diastereomers have different chemical properties, this different behavior 
may be due to factors other than the enantioselective properties of the 
CMA. 
The changes in chiral selectivity between the native and the derivatized 
CD may be due to the loss of hydrogen bonding groups alpha to the chiral 
centers of the CD molecule and/or the gain of additional interaction sites 
about the mouth and the base of the derivatized CD cavity. If there was a 
small number of substituents on the cyclodextrin ring, it appeared that 
these substituents offered additional interaction sites for the analyte without 
prohibiting the formation of an inclusion complex. A large number of 
substituents about the mouth and base of the CD cavity may interfere with 
the fonnation of an inclusion complex, which is thought to be important 
for chiral recognition. 
This study indicated that the degree of substitution on functionalized 
COs was an important factor which may affect the chiral separation 
mechanism. The aqueous solubility of hydroxypropyl J3-CD appeared to 
increase as the degree of substitution increased. Increases in solubility 
allowed larger concentrations of the CMA which may lead to enhanced 
enantioselectivity. Therefore, in using derivatized COs as CMAs, it 
appeared that there was a tradeoff between the enhancement of the 
solubility of the CMA in aqueous media and the stereoselectivity of the 
derivatized CD. The degree of CD substitution should be high enough to 
Table VII. Compounds Separated Using 
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increase the solubility to approximately 0.3-0.4 M, however the 
cyclodextrin should not be exhaustively derivatized since this appears to 
inhibit the formation of an inclusion complex and reduce the 
enantioselectivity for many racemates. A delicate balance must be attained 
so that the degree of derivatization is adequate to increase the selectivity 
and solubility of the CMA but not large enough to obstruct the formation 
of an inclusion complex or to unnecessarily lengthen development times. 
The development times were longer for the derivatized CD than for the 
native CD (in saturated urea solution) because a greater concentration of 
CMA was used and the viscosity of the solution correspondingly increased. 
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D. NATIVE 1)-CYCLODEXTRIN IN REVERSE PHASE HPLC 
The majority of reports of CD-CMA were performed in TLC whereas 
most applications of CD-CSP were in HPLC and gas chromatography 
(GC). Cyclodextrin bonded silica gel can be used as a CSP in LC to 
resolve racemic mixtures of pharmaceutical compounds. The enantiomers 
of 25 different racemic drugs were resolved on CD-CSPs in the reverse-
phase mode and studies were conducted regarding the chiral recognition 
mechanism applicable in these separations. 
Table VIII lists the names, formulae and chromatographic conditions 
of the racemic drugs whose enantiomers were separated using native CO-
bonded CSPs. The k' values listed correspond to the first eluting 
enantiomer; a is the ratio of the first eluting k' value to the last eluting k' 
value, and Rs is the resolution factor. 
All separated drugs, except norgestrel, contain at least one aromatic 
ring. As shown previously (41, 95, 102), the internal toroidal~­
cyclodextrin (~-CD) cavity has a diameter varying from 0.6 nm at the 
bottom to 0.8 nm at the top of the cavity and is relatively non-polar. It 
could easily accommodate molecules or parts of molecules having the size 
of a five, six, or seven-atom aromatic ring. The secondary 2- and 3-
hydroxyl groups of each glucopyranoside ring stand axially at the mouth of 
the CD cavity, forming a polar crown that is most important for chiral 
recognition. 
It was thought that there should be a difference in chiral CD 
recognition between compounds with the chiral center in an acyclic portion 
of the molecule (1 0 1). While this seemed to be a factor, it also appeared 
that the hybridization of the groups attached to the chiral center 
Table VIII. Chromatographic Parameters of the 
Separation of Enantiomeric Drugs 
Therapeutic category & Formula Mobile phase k' a 
drug name %v/v 
Anti-inflammatory agent 
Ibuprofen ~3 MeCH-Buffera (ai3)zCH-CH2 -COOH 70 - 30 8.04 1.1 
Ketoprofen 0 CH3 MeOH-Buffera 7.67 1.06 ~&-cooH 27-73 
Sedative, anticonvulsivant 
Hexobarbital ~,rn3 MeOH-Buffera 9.39 1.14 N 
CH3·CH )=o' 15-85 
N 
Mephobarbital cj;_r3 MeOH-Buffera 14.8 1.14 20-80 :ra 




Phensuximide ai3 MeCN-Buffera 1.97 1.15 I 10-90 0~ 
H 
Etomidate ~ N-cH(CH3)-@ MeCN-B ufferb 2.7 1.46 10-90 No::::( 














Propranolol MeOH-Buffera 2. 78 1.04 1.4 g,h 
~ 25-75 ·Ol2-CHOH·CH2·NH-Ol(Ol3)2 
Metoprolol MeOH-Buffer'l 3.51 
32-68 
1.03 0.9 g,h 
CH~r0i2-o-O-CHr-OiOH-Oiz·NH.ai(CHl): 
Progestrin 
Norgestrel ff= MeCN-Water 0.48 1.24 1.1 1 30-70 
Antihistamine 
Chlorpheniramine MeCN-Buffer'l 5.86 1.07 1.5 g 
Qi...CH ..... 'If(c:Hyz 15- 85 
d-~Va 
Vasodilatator 
Verapamil MeCN-Buffera 2.94 1.03 0.7 g,i 
15-85 


























Compounds under pharmacological investigation 
Idazoxan derivatives 
R =ethyl CQ!o 
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R =phenyl 
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1.03 0.9 g,J 
1.14 1.6 g,h 
1.05 0.8 
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Column 25 em x 4.6 mm i.d. Cyclobond I (~-cyclodextrin). Mobile phase composition 
indicated, MeOH = methanol, MeCN = acetonitrile, flow rate 1 mL/min. Room 
temperature. 
a) 1% (w/v) triethylammonium acetate in water (TEAA), pH 4.1. 
b) 5% (w/v) triethylammonium acetate in water (TEAA), pH 7. 
c) 0.01% (w/v) diethylamine in water. 
d) 1% (w/v) triethylammonium acetate in water (TEAA), pH 5.98. 
e) 1% (w/v) triethylammonium acetate in water (TEAA), pH 4.2. 
f) 1% (w/v) triethylammonium acetate in water (TEAA), pH 7. 
g) Adapted from ref. [13]. 
h) Two 25 em Cyclobond I columns were used in series. 
i) A Cyclobond II column was used (y-cyclodextrin). 
j) A gradient from 10% MeCN to 20% MeCN in 20 min. was used; mean composition 
MeCN 15% v/v. 
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have a significant effect. The highest resolution factor was obtained for 
compounds (i) whose chiral center was part of a ring and (ii) whose chiral 
center was linked to at least two sp2 hybridized carbon atoms (101). The 
highest resolution factor, Rs = 3.7 was obtained for compound SQ 30840 
whose chiral center was part of a ring and is linked to three sp2 hybridized 
carbon atoms. The lowest resolution factor, Rs = 0.7, was obtained for 
flouxetine whose chiral center is not part of a ring and is linked to only one 
sp2 hybridized carbon atom. 
The effects of substituents were demonstrated with the Idazoxan 
derivatives. Figure 19 shows the chromatogram of the methoxy, 
isopropenyl, and phenyl Idazoxan derivatives. The resolution was maximal 
with the two ether substituents (methoxy and ethoxy, Rs = 2.5) and with the 
isopropenyl substituent (sp2 hybridized carbon atom, Rs = 2.3). The 
phenyl substituent, also contains a sp2 hybridized carbon atom; however, it 
produced a slightly lower resolution factor (Rs = 1.3; Table VIII). In this 
case, steric effects must be taken into account and it is likely that the bulky 
phenyl groups interfered somewhat with chiral recognition thereby 
negating the advantage of having an additional sp2 hybridized carbon 
linked to the chiral center. 
The comparison of mephobarbital and mephenytoin was interesting: 
these two compounds are structurally identical, but the carbonyl group 
attached to the chiral center of mephobarbital was missing in mephenytoin. 
Although the CD chiral recognition of the two compounds was similar 
(Rs= 1.6 and 1.8, a= 1.14 and 1.33, respectively); the small carbonyl 
structural change made a tremendous difference in the global retention of 
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Figure 19. Separation of Idazoxan derivatives. Column P-cyclodextrin 250 
x 4.6 mm i.d.; mobile phase: 95% buffer (1% TEAA w/v, pH=4.2)/ 5% 
acetonitrile v/v, 1.5 ml/min; detection: UV 270 nm, 0.01 a.u.f.s. 1,2: 
methoxy derivatives, 3,4: isopropenyl derivatives, 5,6: phenyl derivatives 
L D 
0 2 4 6 8 10 12 14 
T I M E (MIN) 
Figure 20. Separation of D and L norgestrel on a 25 em y-cyclodextrin 
column; mobile phase: acetonitrile-buffer (TEAA 1% w/v) 3ono v/v, 1 
ml/min. The L enantiomer eluted first. 
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that part of the k' difference was due to the mobile phase composition 
(Table VIII). 
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The size of the molecule was also an important parameter in chiral 
recognition by CD. If the molecule was too big to fit inside the CD cavity, 
chiral recognition was hindered. This was the case for norgestrel. The 
two isomers of this steroid were not separated by the ~-CD bonded 
column. The chiral center of norgestrel was part of a ring and has an sp 
hybridized carbon atom. Although there is no aromatic ring in this 
molecule, it should be possible to obtain a chiral separation on CO-bonded 
CSPs. Figure 20 shows the separation obtained on a y-CD-bonded column. 
y-CD has eight glucose units and a larger cavity that can accommodate 
steroids. 
Figure 21 is the circular dichroism spectrum of the two peaks obtained 
with huperzine A. Huperzine A was injected five times and its first and 
second peaks were collected in two different vials. The circular dichroism 
of each collected peak was obtained using a Jasco 1600 polarimeter. The 
two circular dichroism spectra were superimposed in Figure 21. For any 
wavelength, the circular dichroism of the first peak was opposite to the one 
of the second peak. This is absolute proof of enantiomeric separations. 
However, this experiment did not allow the determination of the absolute 
chemical configuration of the enantiomers. Indeed, the D and L structures 
are not systematically linked to a positive or negative light polarization 
rotation. 
Triethylammonium acetate (TEAA) was added at relatively high 
concentration (0.062 M or 1% w/v) in the aqueous fraction of the mobile 
phases to decrease the retention and to improve the efficiency of amino 
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Figure 21. Circular dichroism superimposed spectra of peak 1 and peak 2 
obtained with huperzine A. 
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the COs. This may produce high retention times and peak tailing. The 
addition of 1% , (w/v), of TEAA to the mobile phase can solve this 
problem; the TEA+ ions bind to the silanol groups thereby producing 
sharper peaks for amino compounds ( 41 ). Figure 22 shows the evolution 
of the separation of the etomidate enantiomers. The use of a diethylamine 
(DEA, 0.01 %, v/v) solution (95% and 5% acetonitrile, v/v) produced an 
even better separation. With two columns in series using the TEAA 
buffer, the separation and resolution factors were 1.46 and 0.90, 
respectively (Fig. 22A). With only one column and the DEA mobile phase, 
the separation and resolution factors were 1. 70 and 1.30 respectively (Fig. 
22B). It must be noted that the pH of the DEA mobile phase was 9.5. This 
high pH value could damage the column irreversibly by dissolving the 
silica, cleaving some Si-C bonds and releasing the bonded CDs. However, 
for short periods of time (as in this separation), it is sometimes 
advantageous to use mobile phases at higher pH values. 
These phases are able to resolve enantiomers that cannot be separated 
by the traditional native CD stationary phases. The use of CSPs in LC is a 
new technology that can dramatically improve the quality of chiral drugs 
(1 04 ). A full clinical study of the pharmacological and toxicological 
effects on both enantiomers of any new chiral drug may soon be required 
to obtain an authorization for marketing the drug as a racemic mixture. 
A 
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Figure 22. Separation of R and S etomidate. A: two 25 em Cyclobond I 
columns connected in series; mobile phase: buffer (1% TEAA, 
pH=7)/acetonitrile (90/10 v/v), 0.9 ml/min. B: one 25 em Cyclobond I 
column; mobile phase: water (0.01% v/v diethylamine, pH=9.5)/ acetonitrile 
(95/5 v/v), 0.8 ml/min. 
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E. DERIVATIZED CYCLODEXTRIN IN NORMAL PHASE HPLC 
Several different derivatized ~-cyclodextrins were synthesized and 
used as chiral stationary phases in normal phase liquid chromatography 
(See Figure 23). The multiply substituted derivatives were made with 
acetic anhydride, (R)- and (S)-1-(1-naphthyl)ethylisocyanate, 2,6-
dimethylphenylisocyanate and p-toluoyl chloride. The first successful 
cyclodextrin-based, normal phase separation of enantiomers was 
accomplished on these derivative phases. In contrast to chiral separations 
on the native ~-cyclodextrin stationary phase, the enantiomeric separation 
mechanism on these new phases is not thought to be dependent on inclusion 
complexation. The similarities and differences between the derivatized 
cyclodextrin stationary phases and the cellulosic stationary phases will be 
discussed. 
~-Cyclodextrin has 21 hydroxyl groups available for modification. 
The seven primary 6-hydroxyls are at the "base" or narrow end of the CD 
torus while the fourteen secondary 2- and 3- hydroxyl groups are at the 
"mouth" or wide end of the CD torus. Also, the CD was attached to silica 
gel via its hydroxyl groups through an average of two linkage chains. In 
order to obtain the maximum degree of substitution per cyclodextrin, a 
large molar excess of derivatizing agent was used under vigorous 
conditions. The average degree of substitution for naphthylethylisocyanate 
was- 6; 10, for 2,6-dimethylphenylisocyanate and 13.for p-toluoyl 
chloride. Acetyl modified ~-CD was thought to be about 90% substituted. 
Figure 24 is an idealized model of toluoyl derivatized ~-CD. With the 
exception of the acetyl modified cyclodextrins, the new derivatized CD 
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Figure 23. Derivatized cyclodextrin utilized as chiral stationary phases. 
Table IX. List of Bonded Sorbents 
Amount 
of 
Derivatizing Agent Reagent 
dimethylphenylisocyanate 5g 
p-toluoyl chloride 5g 
(R)-(-)-1-(1-naphthyl)ethylisocyanatea 3g 







a The (R)- and (S)-naphthyl derivatized phases were prepared from 
different lots of CD bonded sorbent. The difference in %C between the 
two phases may reflect the lot to lot substrate variation in surface area, etc. 
However, the degree of substitution is calculated from 
degree of substitution = (J..Lmolesfm2 of naphthyl)/(J..Lmoles/m2 of CD) 
which eliminates the variation due to surface area. 
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chirally selective hydrogen bonding sites as well as additional hydrogen 
bonding sites and aromatic groups for 1t-1t interactions. It appeared that 
cyclodextrins modified with the larger, bulkier substituents consistently had 
a lower degree of substitution. Presumably, this was because of steric 
reasons. Lower degrees of substitution could be obtained by using less 
derivatizing agent and shorter reaction times. An (S)-naphthylethyl 
isocyanate derivatized ~-CD stationary phase, with degree of substitution of 
3, (DS-3) was made in this manner. In comparing the DS-3 and DS-7 (S)-
naphthylethyl isocyanate derivatized-~-CD phases, it was noted that under 
identical conditions, a solute's retention time increased as the degree of 
substitution increased. However, the selectivity (a) did not change 
appreciably for most compounds, provided that low levels of analyte were 
used. 
Most of the prior work done with CD has been in the reversed-phase 
mode but recent developments with derivatized CD columns utilized the 
normal-phase (NP) mode. In the presence of nonpolar solvents (such as 
hexane-isopropanol mixtures) it may be difficult for trace organic solutes 
to form traditional inclusion complexes with cyclodextrins because the 
hydrophobic cavity is presumably filled with the nonpolar solvent and the 
probability of the formation of an inclusion complex is much lower than in 
reversed-phase. However, the presence of aromatic and carbonyl groups in 
modified COs provide opportunities for 1t- 1t interactions that do not exist 
with native cyclodextrins. This, combined with the hydrogen bonding sites 
of the residual hydroxyl groups, provide the type of interactions commonly 
associated with Pirkle-type chiral stationary phases ( 1 05). Furthermore, 
the nonpolar solvents do not compete with the solute for the residual 
hydrogen bonding sites on the cyclodextrin. 
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The first successful CO-based, nonnal phase separation of enantiomers 
was accomplished using derivatized CD-CSP. Figure 24 shows a simplified 
model of toluoyl derivatized ~-CD chiral stationary phase. Table X lists 
twenty different enantiomeric compounds that were resolved on one or 
more of the derivatized cyclodextrin stationary phases. Seven of these 
racemic compounds (Nos. 13,14 and 16-20) also could be resolved on 
native ~-cyclodextrin columns in the reversed-phase mode (31, 1 06), but 
the rest of the compounds could not. For the compounds that were 
resolved on both types of columns, the selectivity (a) obtained on the 
derivatized ~-cyclodextrin columns was comparable or better (and with 
smaller k'-values) than that obtained on the native ~-cyclodextrin columns. 
Also, it should be noted that for compounds 18, 19 and 20, two 
conventional ~-cyclodextrin columns (a 25 em and 15 em column ) used in 
series were required to obtain similar selectivity. 
Occasionally, two different modified CD columns could resolve the 
same racemate (see Nos 3-6; Table X). Figure 25 shows the nonnal phase 
separation of compound No. 4 on two different derivatized ~-CD columns. 
Note the retention and resolution characteristics were significantly 
different. All racemates were tested under a variety of conditions on all of 
the modified CD columns. Each derivatized-CD seemed to have a distinct 
enantioselectivity. Several of the compounds were highly selective for one 
particular stationary phase (Table XI). The seemingly random selectivities, 
column efficiencies and mobile phase requirements of the derivatized CD 
column were analogous to those reported for the modified cellulosic chiral 
stationary phases (107). In general, the isocyanate-derivatized phases 
seemed to have the best selectivity. The resultant carbamate linkage of the 
isocyanate-derivatized phases may provide additional sites for hydrogen 
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Figure 24. Simplified model of toluoyl derivatized P-cyclodextrin. 
COLUMN: TOLUOYL ~-CD 
0 6 12 18 24 
time, min 
COLUMN: PERACETYLATED ~-CD 
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Figure 25. Comparison of toluoyl and peracetylated ~-CD CSP for the 
normal phase separation of (R,R)-(S,S)-N,N'-bis-(a-methylbenzyl)-
sulfamide. The mobile phase was 90/10 (v/v) hexane/isopropanol and the 
flow rate was 1.0 ml/min. The conditions were the same for the two 
chromatograms, the only difference was the stationary phase used. 
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Table X Normal Phase LC separation data for a variety of Enantiomeric solutes on 
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1.10 98:2, hex:ipa 2,6-dimethylphenyl-
isocyanate 
1.20 90:10, hex:ipa R-naphthylethylisocyanate 
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~-CD 
1.07 90:10, hex:ipa R-naphthylcthylisocyanate 
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a hex is the abbreviation for hexane and ipa is the abbreviation for isopropanol. 
R -naphth ylethy I isocyanate 
derivatized-~-CD 
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bonding and/or stronger dipole-dipole interactions relative to the ester 
linkage of the acid chloride-derivatized phases. The naphthylethyl-
isocyanate derivatized ~-CD columns had a definite logic for the separation 
of at least one group of compounds. Solutes that contain an aromatic 7t-
acidic group and an amide, urethane or urea group usually were resolved. 
Derivatization of analytes (such as chiral amines, alcohols, carboxylic 
acids, etc.) by the addition of a 3,5-dinitrobenzyl group expanded the 
range of compounds which could be separated by providing additional sites 
for interaction with the chiral agent. In this respect, the 
naphthylethylisocyanate derivatized-CD phase was somewhat analogous to 
the naphthylvaline reciprocal CSPs developed by Pirkle and Pochapsky 
(1 08). 
As has been noted, there are a number of analogies that can be drawn 
between the derivatized cyclodextrin bonded phases and modified cellulosic 
phases. For example, both are modified carbohydrates containing glucose 
monomer units. Many of the substituents attached to the 2-, 3- and 6-
hydroxyl groups of cellulose and cyclodextrins are identical (i.e., acetyl 
and toluoyl) or analogous (i.e., the aromatic isocyanates). However, there 
are a number of important differences in these two classes of chiral 
stationary phases which can significantly affect the chromatographic 
approach and results. A comparison of these two classes of CSP is given in 
Table XI. One of the obvious differences is that the derivatized 
cyclodextrins are discrete molecules covalently bonded to silica gel while 
the cellulosic CSPs consist of a distribution of polymers that are adsorbed 
onto silica gel. As a result, the cellulosic phases are limited to fairly large 
pore-size silica gels (e.g., > 300A), so that the cellulose polymer can go 
into the pores and coat the internal surface) while the 
I 0 I 
Table XI. Comparison of Derivatized Cyclodextrin 
and Derivatized Cellulosic Chiral Stationary 
Phases for Normal Phase LC Separation 
Derivatized Cyclodextrin 
1. Individual molecules 
covalently bonded to silica gel. 
2. No solvent restrictions except 
for strong acids and bases. 
3. Can be stored at room 
temperature indefinitely in typical 
nonnal phase solvents. No 
irreversible conformational 
changes that affect chiral 
recognition are possible. 
4. Can be bonded to a variety of 
different pore-size silica gels (60-
300A). 
5. Highly purified derivatives can 
be crystallized thereby allowing 
computer modeling and 
theoretical evaluation of 
enantioselective properties. 
Derivatized Cellulose 
I. Distribution of polymers 
adsorbed on silica gel. 
2. Must avoid halogenated solvent 
or any other mobile phases that 
will dissolve and remove the 
substituted cellulose. 
3. Storage recommended hexane 
at -4 °C. Upon standing at room 
temperature, polar organic 
modifiers (isopropanol, etc.) 
sometimes can cause an alteration 
in the secondary structure of 
adsorbed cellulose polymers 
resulting in a loss of chiral 
recognition. 
4. Must be adsorbed on a large 
enough pore size silica gel 
( -300A) that the polymer can 
enter the pore. 
5. Cannot be crystallized at the 
present time. Secondary structure 
that contributes to enantio-
selectivity is unknown. 
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derivatized-CD CSPs are not. At least two precautions must be observed 
with the coated chiral stationary phases that are unnecessary with bonded 
varieties. For example, mobile phase solvents that dissolve the polymer 
(such as halocarbons, THF, etc.) must be strictly avoided for the cellulosic 
CSPs as they quickly strip the derivatized cellulose from the silica gel. 
Also, there seems to be a definite secondary structure to the adsorbed 
cellulose polymer which leads to chiral recognition. If this secondary 
structure is altered or changed, enantioselectivity could be lost even though 
the chiral polymer remains on the silica gel. Storing these columns in 
mobile phases containing a more polar solvent (such as isopropanol) at 
room temperature was sometimes sufficient to cause a change in the 
secondary structure of the polymer. 
Despite the empirical similarities between the derivatized cyclodextrin 
and derivatized cellulosic stationary phases, they do not have identical 
enantioselectivities. There were racemates that have been resolved on the 
derivatized-CD columns that have not been resolved on the analogous 
cellulosic phases (e.g., compounds 5 and 19 of Table X) and vice versa. 
Other racemates could be resolved on both phases thereby giving one a 
choice. Having such a choice frequently is useful since the efficiency, 
selectivity, loading capacity, retention time, optimal solvent composition, 
cost, etc. usually differ for different CSPs. 
As the number of available chiral stationary phases increases, there is 
bound to be overlap in the types of compounds separated. Clearly, more 
studies need to be done comparing many of the existing columns. This is 
likely to occur in the near future. 
103 
F. AMINO ACID STUDY 
The column switching set-up for this study is shown in Figure 26. 
The general racemization profile versus pH for many free amino acids is 
illustrated in Figure 27. Typically there are minima between pHs of 0 to 3 
and a plateau region between pHs 3 to 7 (1 09). At very high (> 12) and 
low(< 0) pHs, the rate of racemization increases substantially. In addition 
to pH, racemization rates also are influenced by temperature, ionic 
strength, presences of metal ions and so forth. Each amino acid has an 
individual racemization profile and rate. Aspartic acid, for example, has a 
small maximum at pH - 3.8 and another minima at pH - 5.0 (1 09). One 
goal of the analytical methodologies developed for this work was to 
minimize the effect of racemization on the measured enantiomeric purities. 
Hence most samples were analyzed immediately after they were obtained. 
The analyses were complete within 45 minutes from sample introduction. 
No pH or temperature extremes that could lead to high racemization rates 
were used at any time. No precolumn reaction or derivatization of the 
amino acids were done (see Materials and Methods). 
Each analytical system was "tested" with commercial L-amino acid 
preparations. Typical results for five amino acids are shown in Table XII. 
D-amino acids were found in all commercial samples although some were 
at very low levels. Clearly, analytical methodologies for detennining 
enantiomeric purities are reaching high levels of sophistication and 
sensitivity. In many cases the sensitivity is such that an enantiomeric 
impurity is almost always found (Table XII). Of the L-amino acids 
evaluated, tryptophan usually had the lowest levels of the "unnatural" D-
amino acid. It was not unusual to see tenths of a percent and occasionally 
pump 1 
to waste 








Figure 26. Schematic showing the coupled column (i.e., achiral-chiral) 
system used for the determination of the enantiomeric purity of amino acids 
in urine. Note, when electrochemical detection was used (detector 2) there 
was no post-column derivatization. When fluorescence detection was used 















Figure 27. Plot showing the rate of L:D interconversion versus pH for 
phenylalanine and leucine at 142°C. Data redrawn from Bada (1985). 
105 
Table XII. Data Showing the Amount of Contaminating D-Enantiomers in Commercial 











2.9 X 10-1 
8.0 X 10-1 
3.9 X 10-1 
4.1 X 10-1 
6.5 X 10-1 
Methionine 
%Da 
4.2 X 10-3 
6.0x 10-3 
5.0 X 10-3 
3.3 
3.8 x 10-1 
Ornithine 
%Da 
1.7 X 10-3 
7.6 X 10-2 
3.9 X 10-1 
3.5 X 10-2 
3.0 X lQ-2 
Tyrosine 
%Da 
3.6 X 10-2 
2.1 X 10-2 
6.5 x 1o-3 
2.9 X I0-2 
1.5 X 10-3 
Tryptophan 
%Da 
1.9 X 10-3 
5.7 X 10-3 
8.9 X 10-4 
7.3 X 10-3 
1.0 X IQ-3 
a% D denotes the% D-amino acid enantiomer present in the commercially available L-amino acid samples. All samples were prepared 
immediately prior to analysis. Conditions for separation are indicated in the experimental section. -
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percent levels of the D-enantiomers. There were significant batch to batch 
differences in the enantiomeric purity of individual amino acids from the 
same company. These variations often were as great as the variations 
between companies (Table XIII). It might be interesting to consider the 
effect that the varying levels of enantiomeric impurities could have on 
some of the numerous biological, biochemical and medicinal experiments 
that utilize these amino acids. Figure 29 shows the chromatographic 
separation of D-cysteine and D-tryptophan from the dominant L-
enantiomer in two commercial samples. 
Several essential amino acids were analyzed in human urine, blood 
serum and amniotic fluid. Because of the large number of contaminating 
compounds and high ionic strength, it was not advisable to directly inject 
biological samples onto a chromatographic chiral stationary phase (CSP). 
A column switching procedure was essential for accurate results and for 
increasing the longevity of the CSP. The amniotic fluid samples were 
much cleaner than the urine and the blood serum samples but the same 
precautions were taken. The fresh sample was directly injected onto a 
reversed phase C18 column which separated the amino acids from one 
other as well as from the other compounds in the sample. Figures 29, 30 
and 31 show typical C18 chromatograms of urine, blood serum and 
amniotic fluid, respectively. Upon elution, the amino acid of interest was 
then switched onto the CSP for enantiomeric resolution and quantitation. 
Figure 32 shows the enantiomeric separation of phenylalanine from human 
urine on a chiral crown ether column ( 11 0). Figure 33 shows the 
enantiomeric separation of tyrosine from human blood serum utilizing the 
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Figure 28. LC chromatograms used to evaluate the enantiomeric purity of 
L-cysteine from Fluka and L-tryptophan from Sigma. Electrochemical 
detection was used in both cases. For chromatogram A, the mobile phase was 
pH 1.5 aqueous HCl04; the flow rate was 0.1 ml/min; the voltage was +0.50v 
and the gain was 1x50. For chromatogram B, the mobile phase was pH 1.5 
aqueous HCI04; the flow rate was 0.8 ml/min; the voltage was +0.50v and 
the gain was 10x5. 
Table XIII. Batch Comparison for L-amino acids 
from company D 
Amino Acid %Din Batch 1 %Din Batch 2 
Cysteine 0.405 1.109 
Methionine 3.35 2.32 
Tyrosine 0.029 0.029 
Tryptophan 0.073 0.038 
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Note: Batch 2 material was ordered in preparation for the commercial 






















Figure 29. A C18 chromatogram for the direct injection of urine. Peaks for 
four amino acids (Leucine, tyrosine, phenylalanine and tryptophan) are 
indicated. UV detection at 200 nm was used. The injection volume was 20 
ml, the flow rate was 1.5 ml/min and the mobile phase consisted of 5:95 (v:v) 
methanol:5xl0-3M HCl04. Note: in this chromatogram the peak labeled 
tryptophan actually consists of tryptophan plus another impurity. However, 
these two components are resolved when using a mobile phase consisting of 











Figure 30. A C18 chromatogram for the direct injection of blood serum. 
UV detection at 200 nm was used. The injection volume was 20 J.il, the 
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Figure 31. A C18 chromatogram for the direct injection of amniotic fluid. 
UV detection at 200 nm was used. The injection volume was 20 ~1, the 
flow rate was 1.0 mVmin and the mobile phase 5:95 (v:v) MeOH:H20. 
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electrochemical detection, while others must undergo postcolumn 
derivatization to form a fluorescent analogue (see Experimental Section). 
Table XIV summarizes the analytical data for four of the amino acids 
found in human urine. The total levels of these amino acids were within 
ranges previously reported for human urine (Ill). Trace levels of the 
"unnatural" D-amino acids were found in all cases. The relative amounts 
of D-amino acids present in these samples ranged from several hundredths 
of a percent to percent levels (Table XIV). In general, there were greater 
amounts of D-amino acids found in human urine than were found in 
commercial standards for L-amino acids (Table XII). The range of total 
amino acid concentrations as well as the percent 0-enantiomer content 
varied not only from person to person but also for one person from day to 
day. For example, in the case of the phenylalanine data in Table XIV, both 
the high (5.1%) and low (0.3%) values came from two different specimens 
provided by the same individual two weeks apart. In general, the relative 
amount of 0-phenylalanine was greater than that found for 0-tyrosine and 
D-tryptophan. There did not seem to be a correlation between the total 
amino acid concentration in urine and the relative amount of the D-
enantiomer. 
In order to quantitate the low levels of 0-amino acids, relatively large 
samples (20 - 200 J.ll) had to be injected. If amino acid levels were too 
low, a preconcentration step was necessary. This was the case for some of 
the amino acids not reported in this work. Although preconcentration 
increased the level of the trace analyte in a given volume of sample, it also 
increased the level of interfering contaminants. This could lead to 
overlapping peaks or column overloading and poor resolution. 
Lypholization seemed to be the most effective way to 
1 1 4 
Table XIV. Summary of Free Amino Acid Data 
from Human Urine Specimens 
Number of Urine Total Range of AA % D-Amino Average% 
Amino Acid Samples Analyzed Concentration mMIL Acid, Range D-Amino Acid 
Phenylalanine 11 35 - 130 0.3- 5.1 1.9 
Tyrosine 9 45 - 210 0.1-0.?a 
Tryptophan 8 46- 280 0.06- 0.4 0.2 
Leucine 3 b b b 
aone result (i.e., 6.6% D-tyrosine) was excluded from this data as it was 
approximately an order of magnitude higher than the next closest value. 
Four different individuals provided all samples for this study. However, 
the high tyrosine value (vide supra) was the sole sample provided by one 
individual. Currently, it is not known if this high value is legitimate or is 
due to an impurity or some other error. 
bpeaks were obtained for both the D- and L-leucine. However, neither 
peak was baseline resolved from other contaminate peaks. This made 
accurate quantitation difficult. Although we are reasonably confident that 
some D-leucine is present, we would prefer to improve the analytical 
methodology somewhat before reporting any numbers. 
I I 5 
concentrate excreted amino acids. Solid phase extraction of amino acids 
from urine proved to be ineffective. Solid phase extraction of amino acids 
was performed with the blood serum samples to remove proteins. Table 
XV compares the measured levels of D-tryptophan and D-tyrosine in 
lypholized urine samples versus untreated urine samples that were analyzed 
directly. The lypholization step did not affect the measurement of D-
tryptophan in urine. However,the apparent amount of D-tyrosine in 
lypholized urine was anomalously high (Table XV). This was thought to 
be the result of overlapping impurity peaks rather than to racemization 
during lypholization. However, further investigations must be completed 
before racemization can be completely disregarded. 
Table XVI summarizes the analytical data for three of the essential 
amino acids found in human blood serum. The total levels of these amino 
acids were within ranges previously reported for human blood serum. 
Trace levels of D-amino acids were found in some cases. The relative 
amounts of D-amino acids were lower than that reported for human urine. 
Each person donated a single sample, so individual variations were not 
studied. The lowest concentration of D-amino acid was found for 
phenylalanine and the highest concentration was for tyrosine. No 
"unnatural" 0-amino acids were detected in the amniotic fluid samples for 
the four amino acids analyzed. The limit of detection was 0.05%. 
This study provides evidence for the presence of free 0-amino acids 
in human urine and blood serum. In some cases the "unnatural" D-
enantiomer was present at percent levels relative to the corresponding L-
amina acid concentration. However, somewhat lower levels were more 
common. Care must be taken to resolve the amino acids of interest from 
other similarly retained components so as not to overestimate the amount 
Table XV. Data Showing the Effect of a Freeze-Drying Preconcentration Step on the 




Range of D-Amino Acids 
Perconcentration by 
Direct Injection lypholization 
0.1 - 0.36 0.06- 0.6 
0.1 to 0.70 3.0 to 9.2 
Average % D-Amino Acid Concentration 
Preconcentration by 
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of the D-enantiomer. Any biochemical, physiological or clinical 
significance of these enantiomers has yet to be established. Certainly there 
are a number of interesting possibilities. Many past studies on the 
efficiency of free amino acid reabsorption by the kidney have not taken 
into account possible differences in the rates or mechanism of D- versus L-
amino acid absorption, for example. 
11 8 
Table XVI. Summary of free amino acids data 
from human blood serum samples 
Number of Urine Total Range of AA % D-Amino Average% 
Amino Acid Samples Analyzed Concentration mM/L Acid, Range D-Amino Acid 
Phenylalanine 13 35 - 130 <0.05-1.00 0.10 
Tyrosine 8 45- 210 <0.05-0.51 0.31 
Leucine 4 a <0.05 <0.05 
a Same as Table XIV. 
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T I M [, M I N. 
Figure 32. Chromatogram showing the enantiomeric purity of 
phenylalanine from the direct injection of a urine sample onto the coupled 
column system (Figure 26). The conditions for the C18 separation were the 
same as in figure 29. Note the absence of interfering peaks. A chiral crown 
ether column was used at room temperature. The mobile phase consisted of 
0.02 M HC104, and the flow rate was 0.5 ml/min. Fluorescence detection 
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Figure 33. Chromatogram showing the enantiomeric purity of tyrosine 
from the direct injection of a human blood serum sample onto the coupled 
column system (Figure 26). The conditions for the C18 separation were 
the same as in figure 29. Note the absence of interfering peaks. A chiral 
crown ether column was used at room temperature. The mobile phase 
consisted of 0.02 M HCl04, and the flow rate was 0.5 mVmin. 
Electrochemical detection was used: v=+0.5volts. 
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CONCLUSIONS 
Chiral mobile phase additives were studied in both normal and reverse 
phase thin layer chromatography. N-carbobenzoxy-glycyl-L-proline and 
(1 R)-ammonium-1 0-camphorsulfonate were effective CMAs for various 
aromatic amino alcohols, but it was not possible to obtain chiral separations 
unless the solvents were properly dried. Derivatized ~-cyclodextrins 
proved more soluble in hydro-organic solvents than the native ~-CD. 
Maltosyl- and hydroxypropyl-~-CD were useful as CMAs but dimethyl-~­
CD was not. It was determined that the degree of substitution of the 
derivatized CD can effect the viscosity of the mobile phase, the time of 
development and the enantioselectivity. In enantiomeric separations 
involving CMAs two parameters had to be optimized to develop a plausible 
TLC technique. The first parameter was the type of TLC plate utilized and 
the second parameter was the mobile phase composition. 
Native and derivatized ~-CD chiral stationary phases were successful in 
resolving a variety of chiral analytes in reverse and normal phase high 
performance liquid chromatography, respectively. Results indicated that 
the enantioselectivity can be different for some compounds when 
comparing the different types of derivatized CD columns. The same can be 
said of a comparison of the derivatized cyclodextrin and the derivatized 
cellulosic stationary phases. 
The potential of CSPs based on CDs is tremendous, and recently CD 
derivatives that can be used as CSPs in gas chromatography have been 
developed (103). Derivatized COs can be used in LC to improve chiral 
separations or to extend the applicability of such CSPs. Currently this 
research group is completing experiments on the use of derivatized COs as 
stationary phases for both reversed and normal-phase LC. 
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In a comparison between the L-amino acid product of six prominent 
companies, the range of D-amino acid impurity was from 1.0 x Io-1 to 8.9 
x I0-4%. Although the human body is known to be composed of L-amino 
acids, experimental results indicated that there are trace to percent levels of 
D-amino acids in blood serum and urine. There were no detectable levels 
of D-amino acids found in human amniotic fluid. 
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